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The rate of adolescent Cannabis abuse is increasing for recreational purposes and 
it is thought to be linked to a range of developmental and social problems. Many studies 
have demonstrated effects of early Cannabis exposure to produce behavioral effects that 
persist through adulthood. However, the physiological changes in the CNS that must be 
responsible for this altered behavior remain poorly understood. Delta-9-
tetrahydrocannabinol (THC) is a psychoactive cannabinoid isolated from Cannabis that 
exerts its effect by partially-activating cannabinoid receptors. Adolescence is a critical 
period for brain development and maturation. Zebra finches are songbirds that learn vocal 
patterns during a sensitive period of development that approximates adolescence. 
Exposure of these animals to a cannabinoid agonist during their period of sensorimotor 
vocal learning alters song patterns produced in adulthood. Thus, songbirds have unique 
value in studying developmental effects of drug exposure on a naturally learned behavior. 
We have adapted place preference methods to study cocaine reinforcement of behavior. 
Moreover, we pharmacologically manipulated 2- arachidonoyl glycerol (2-AG) levels 
using JLZ-184 (a selective inhibitor of MAG lipase, the enzyme responsible for 
 
 
degradation of 2-AG) to determine if augmentation of the endogenous cannabinoid 
signaling produced THC-like increased cocaine sensitivity. We have found that cocaine 
dose-dependently reinforces both place preference and aversion at potencies consistent 
with those observed in mammalian species. THC persistently increases sensitivity to 
cocaine through adulthood. However, developmental exposure to JZL-184 induced 
aversion. These effects were not observed following treatment of adults. Moreover, the 
expression of c-Fos (a marker of neuronal activity) was increased in Area X of striatum in 
THC-treated animals and nucleus taeniae of amygdala in JZL-184-treated animals. Also, 
elevated dopamine (DA) and 3,4-Dihydroxyphenylacetic acid (DOPAC) levels were 
observed in Area X and VTA only in animals that developmentally treated with THC. On 
the other hand, we have found that developmental chronic THC and JZL-184 exposure 
resulted in alteration of the song phonology that persist through adulthood. 
 This indicates that normal endocannabinoid signaling is important to vocal 
learning, and agonism or antagonism of these processes disrupts this learning, indicating 
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CHAPTER 1: INTRODUCTION 
1.1 Cannabis Abuse in Adolescence  
Use or abuse of illicit drugs mostly starts at early age during the teen and young 
adult years (Samsha, 2012). Statistics show that approximately 50,000 of American 
school students in 8th, 10th, and 12th grades had used illicit drugs such as alcohol, 
cocaine, nicotine, LSD, heroin, amphetamine, and marijuana in their lifetime (Johnson, 
O’Malley, Bachman, & Schulenberg, 2013). The drinking of alcohol comes in the first 
place in terms of substances abused among 13 and 14 years old, followed by marijuana 
(Chadi, Bagley, & Hadland, 2018). Marijuana is used widely for recreational purposes due 
to its availability to adolescents despite laws making possession a serious crime in many 
countries, including the United States. Although annual use of marijuana among 
teenagers decreased in prevalence from 50% in 1970s to 36% in one recent survey, it is 
still considered a threat for the young adult that causes negative consequences including 
social and health problems (Chadi et al., 2018). As the teenager’s brain continues to 
develop, any use of illicit drugs during this critical period of life causes many social and 
health problems that persist through adulthood. Social problems including violence, car 
accidents, and sexual assaults are higher in adolescents who use illicit drugs compared 
to those who do not (Decker et al., 2014; Senn, Carey, & Vanable, 2010). In addition, illicit 
drugs result in altered neurodevelopment and associated cognitive and behavioral 
functioning (Chadi et al., 2018). Neuroimaging studies have shown a decrease in the 
volume of some brain structures such as hippocampus and prefrontal cortex (PFC) in 




memory (Chadi et al., 2018). Moreover, positron emission tomography (PET) in human 
studies revealed that repeated and regular cannabis use downregulated the cortical 
CB1R (Hirvonen et al., 2012).  Also, functional imaging studies showed that cannabis 
abuse reduces activity in brain regions that are involved in memory and attention (Block 
et al., 2002).   
1.2 Adolescence is a Critical Period of Brain Development and Learning 
1.2.1 White and Gray Matter Changes  
Adolescence is a critical period for brain development and maturation. During the 
brain maturational processes many changes occur in the context of physiological and 
social transitions. These changes have an important influence on cognitive function, 
behavior and emotional processing. Adolescent brain size continues to increase through 
adulthood (Pfefferbaum et al., 2012). Increases in the white and decreases in the gray 
matter volume and density in brain regions that are important for memory, attention, and 
cognitive ability occur during childhood and adolescence. Moreover, these changes 
include maturation of the neuronal circuity and white matter connections and increase the 
synaptic density in the cortical regions and limbic system (Barnea-Goraly et al., 2005; 
Paus et al., 1999).  
1.2.2 Development Neurotransmitter Systems  
Neurotransmitter systems also appear to develop during adolescence including 
the dopaminergic, GABAergic, and glutamate NMDA receptor systems (reviewed by He 




is important for PFC function and that of the limbic system which includes the 
hippocampus, amygdala, nucleus accumbens (NAc), and VTA (Arnsten, Cai, Murphy, & 
Goldman-Rakic, 1994; Constantinidis, Williams, & Goldman-Rakic, 2002; Sawaguchi & 
Goldman-Rakic, 1991; Vijayraghavan, Wang, Birnbaum, Williams, & Arnsten, 2007).   
1.2.2.1 Dopaminergic System  
Dopamine (DA) is a neurotransmitter that belongs to the catecholamine family that 
plays a role in a variety of physiological functions (i.e. motivation, attention, movement, 
and hormone regulation) and pathophysiological conditions (i.e. Parkinson’s disease), 
Berridge, Robinson, & Aldridge, 2009). L-DOPA is the primary precursor for DA synthesis 
by the enzyme aromatic L-amino acid decarboxylase (DOPA decarboxylase) in the 
presence of a cofactor pyridoxal phosphate. L-DOPA itself is synthesized from L-tyrosine 
by tyrosine hydroxylase (TH, the rate limiting step) with tetrahydrobiopterin, O2, and iron 
(Fe++) as cofactors (reviewed by Björklund and Dunnett 2007). Synthesis of DA takes 
place in cell bodies in the brain (neurons) and kidneys (adrenal glands) (reviewed by 
Björklund and Dunnett 2007). After synthesis, DA will be stored in synaptic vesicles and 
released into the synaptic clefts in response to action potentials. DA then binds to DA 
receptors (either post or presynaptic receptors) in the synapse. After that, DA can be 
taken up back by dopamine transporters (DAT) into the pre-synaptic cells or broken down 
by enzymes. There are a set of enzymes that are responsible of DA degradation including 
monoamine oxidase (MAO), catechol-O-methyl transferase (COMT), and aldehyde 
dehydrogenase (ALDH) and the main end products are dihydroxyphenylacetic acid 
(DOPAC) and homovanillic acid (HVA) (Eisenhofer, Kopin, & Goldstein, 2004). 




nigra and ventral tegmental area (VTA). The dopaminergic neurons in substantia nigra 
pars compacta are projecting to dorsal striatum (known as nigrostriatal pathway) and play 
an important role in the control of motor functions (reviewed by Björklund and Dunnett 
2007). Damage to these neurons can lead to Parkinson’s disease. Whereas the 
dopaminergic neurons in the VTA are projecting to the prefrontal cortex (PFC, known as 
the mesocortical pathway) and the Nucleus accumbens (NAc, mesolimbic pathway) and 
together both of these pathways are known as the mesocorticolimbic pathway. In addition, 
the VTA is also projecting to other parts of the brain including amygdala and 
hippocampus. The mesocorticolimbic pathway plays a significant role in reward and 
motivation (reviewed by Björklund and Dunnett 2007). DA release normally occurs in 
response to a stimulus (i.e. food, exercise) that creates an action potential in the DA 
neuron (Berridge et al., 2009). However, in the case of the drugs of abuse such as cocaine 
and methamphetamine, the levels of DA in the synapses will be higher than normal 
because of the DAT blocking and facilitating its release from the nerve endings (reviewed 
by Ikemoto, Yang, and Tan 2015). DA is the main molecule that has been well studied 
and investigated in addiction research as most drugs of abuse including alcohol, nicotine, 
and opioids were found to increase its synaptic levels by different mechanisms (reviewed 
by Ikemoto, Yang, and Tan 2015). 
The activity of the dopaminergic system rises and peaks through adolescence and 
then stabilizes during adulthood (Tarazi & Baldessarini, 2000). For example, Tarazi and 
his colleagues demonstrated that DA subtype receptors density including D1, D2, and D4 
in frontal cortex and hippocampus increased by several fold in postnatal days 35-60 in 




humans to study DA receptor densities, and radioligand binding studies examining 
dopamine 1 receptor (D1R) densities, a reduction of 14–26% in the in the adult group 
compared to adolescents in the striatum and cerebral cortex were observed (Jucaite, 
Forssberg, Karlsson, Halldin, & Farde, 2010). In addition, DA transporter density was 
found to be increased by 6-7-fold in caudate-putamen (CPu, one of the structures that 
composes the basal ganglia) and NAc of rat brain in postnatal days 7-60 (Tarazi, 
Tomasini, & Baldessarini, 1998). Levels and activity of catechol-o-methyltransferase 
(COMT, one of the enzymes responsible for catecholamine degradation) are reported to 
increase two-fold from neonate to adulthood in primate PFC (Tunbridge et al., 2007). 
Also, immunohistochemistry studies showed that the level of TH, the rate-limiting enzyme 
involved in DA synthesis, peaks in PFC during the late-postnatal period and then declines 
in adulthood (Rosenberg & Lewis, 1994). In one study, haloperidol responsiveness and 
sensitivity was tested in different age groups to compare between younger and adult rats 
finding that the younger group was more sensitive to haloperidol in a manner associated 
with increased DA turnover in striatum and NAc - demonstrating that haloperidol was 
more potent in younger animals (Teicher et al., 1993). Progressive decreased expression 
of elements of the dopaminergic signaling system neurotransmission from adolescence 
to adulthood suggests that this period of life is critical in context of brain maturation, 
development and related psychopathology. Any external intervention to alter CNS activity 
during this critical period (adolescence) may have persistent consequences both negative 




1.2.2.2 The GABAergic (γ-aminobutyric acid) System 
The GABAergic system, controlled by the major inhibitory neurotransmitter in the 
brain, is another system that is undergoes remarkable changes during adolescence and 
has a major role in cortical remodeling (reviewd by He & Hodge, 2007). In one study, 
amygdala fibers that form synaptic connections with the GABAergic interneurons in the 
PFC have been found to be largely increased during adolescence (Cunningham, 
Bhattacharyya, & Benes, 2008). The density of pre- and postsynaptic markers of GABA 
neurotransmission increased in the PFC of monkeys during adolescence (Lewis, Cuz, 
Eggan, & Erickson, 2004). In addition, Kellogg and his colleagues reported that the 
GABAA receptor density in adolescence was higher in the cortex compare to adults 
(Kellogg, Taylor, Rodriguez-Zafra, & Pleger, 1993). Also, it was reported that the GABA 
system may play a role in hippocampus formation when Hachiya and Takashima found 
that GABA transporter 1 (GAT-1) and glutamic acid decarboxylase (GAD) expression, a 
marker for GABAergic neurons, peaked in early infancy (Hachiya & Takashima, 2001). 
GABAA receptor α1 subunit, that mediates some of the pharmacological effects such as 
sedation and anticonvulsant actions, expression was found to be increased in the PFC in 
adolescents followed by a reduction during adulthood  (Yu, Wang, Fritschy, Witte, & 
Redecker, 2006).     
The maturation of GABAergic signaling from infancy to adolescence to adulthood 
is important as it is contributing to brain development and related behaviors including 
cognitive control, risk taking, and decision making (Silveri et al., 2013). Any intervention 




GABA system that may result in alcohol dependence and other drug addiction through 
adulthood.  
1.2.2.3 Glutamate and NMDA Receptor Systems 
In one of the in vitro receptor autoradiography studies in rat forebrain that was 
conducted by Insel and his colleagues, they found that the binding of glutamate to its N-
methyl-D-aspartate (NMDA) receptors increased in adolescents compared to adults 
(Insel, Miller, & Gelhard, 1990). Moreover, NMDA-receptor dependent long-term 
potentiation (LTP), a measure of synapse strength, was more frequent in NAc in 
adolescent  (3 weeks old) mice compared to adulthood (Schramm, Egli, & Winder, 2002). 
In addition, LTP and plasticity were also reported in other brain regions such as VTA (M. 
J. Thomas, Beurrier, Bonci, & Malenka, 2001), amygdala (Ungless, Whistler, Malenka, & 
Bonci, 2001), and hippocampus (Walter Adriani et al., 2004). 
Addictive drugs are known to modulate the maturation of neurotransmission during 
adolescence (Crews, Rudolph, & Chandler, 2002). Thus, the impact of the environmental 
factors, such as abusing illicit drugs, is critical to understanding how adolescents are more 
vulnerable to drug addiction.   
1.2.3  Learning New Skills During Late-Postnatal Development 
Adolescence is a critical period of development where learning ability is active. At 
this critical period, learning new skills or traits are easier due to the physiological changes 
and development that occur in the brain. Examples of skills that are acquired and learned 
during this time are language, sports, music, communication and memory (He & Hodge, 




age of life and ends in puberty and demonstrates that language acquisition is unique to 
childhood (Grimshaw, Adelstein, Bryden, & MacKinnon, 1998). In addition, it was reported 
that children who grew up in isolation or had hearing impairment did not develop their first 
language normally because they miss sensory inputs during a critical window of learning 
in the first years of life (Friedmann & Rusou, 2015).  
In terms of memory, one spatial working memory task study that had been 
conducted in a group of adolescents (9 to 20 years old) showed improvement in working 
memory abilities including developing the recall-guided action for single units of spatial 
information, maintaining and manipulating multiple spatial units, and strategic self-
organization. PET studies showed the spatial working memory tasks activate ventrolateral 
PFC (Luciana, Conklin, Hooper, & Yarger, 2005). This development of working memory 
abilities was found to recruit the frontal lobe regions that continue to develop over 
childhood and adolescence (Conklin, Luciana, Hooper, & Yarger, 2007). A weight of prior 
evidence suggests the importance of this period of development.  
1.3 Cannabis-related Phytocannabiniod 
Cannabis is known to have been used by the ancient Chinese, Indian, Egyptian 
and Assyrian civilizations for both medical and recreational purposes (Mechoulam & 
Parker, 2013). Approximately 115 different cannabinoids have been isolated and 
identified from the Cannabis plant but Δ9-tetrahydrocannabidiol (THC), cannabidiol 
(CBD), and cannabinol (CBN) are the most well-studied constituents (Aizpurua-Olaizola 
et al., 2016). THC is the principal psychoactive constituent of Cannabis and was first 




experience mental and physical effects including euphoria, increased appetite and heart 
rate and impaired coordination (Anderson, 2018). When smoked, its effects begin within 
minutes of use and reaches peak levels shortly afterward in about 10 to 30 minutes. As 
THC is a lipid, it partitions to fat that may serve as a slow release depot, making the 
influence of THC last for a longer time than expected based upon blood levels (Anderson, 
2018). It was formerly believed that THC exerted its effects by a general nonspecific 
mechanism by binding to and altering the structure of neuronal cell membranes. This view 
was disproven following discovery of the cannabinoid 1 receptor (CB1R) in 1988 by 
Devane & Howlett (Devane, Dysarz, Johnson, Melvin, & Howlett, 1988). THC is behaving 
like the endogenous chemical, anandamide, as partial agonist at CB1 receptors and 
displaying lower affinity at CB2 receptors (reviewed by Pertwee, 2008). In many studies, 
administration of THC was found to increase brain reward effects as it increases place 
preference and self-administration of a number of drugs of abuse such as heroin, 
methamphetamine, and alcohol (Panagis, Mackey, & Vlachou, 2014) 
Cannabidiol (CBD) is a phytocannabiniod that was discovered in 1940. CBD is a 
non-psychoactive constitute that does not produce the similar psychoactive effects of 
THC. Depending on strain, CBD may account for up to 40% of the Cannabis plant’s 
extract (Campos, Moreira, Gomes, Del Bel, & Guimaraes, 2012). CBD has been variously 
studied in clinical research for its effects and role in pain, anxiety, cognition, and 
movement disorders (Boggs, Nguyen, Morgenson, Taffe, & Ranganathan, 2018). CBD 
showed a little affinity for CB1 and CB2 receptors (Mechoulam, Peters, Murillo-Rodriguez, 
& Hanuš, 2007). However, CBD was found to work as an antagonist for the cannabinoid-




transfected cells (A. Thomas et al., 2007). Moreover, multiple evidence demonstrates that 
CBD effects are mediated by a number of receptors (Reviewed by Boggs et al., 2018). It 
was reported that CBD produces its effects such as antidepressant-like effect and 
anxiolytic effect by binding to the serotonin 1A (5-HT1A) receptor in rodent models 
(Fogaça, Reis, Campos, & Guimarães, 2014; Sartim, Guimarães, & Joca, 2016).  Also, 
other reports demonstrated interactions between CBD and G protein coupled receptor 55 
(GPR55), μ and δ opioid receptors, and transient receptor potential vanilloid type-1 
(TRPV1) cation channels (reviewed by Pertwee, 2008). Recently, the Food and Drug 
Administration (FDA) of the United States has approved marketing of the CBD 
formulation, Epidiolex, for the treatment of epilepsy (FDA, 2018). 
Cannabinol (CBN) is another phytocannabiniod that is found in trace amounts in 
the Cannabis plant (Karniol, Shirakawa, Takahashi, Knobel, & Musty, 1975). Also, CBN 
is a metabolite of THC degradation (McCallum, Yagen, Levy, & Mechoulam, 1975). CBN 
is a mildly psychoactive constitute compared to THC and binds partially to CB1R  and 
has high affinity at CB2R (Mahadevan et al., 2000).  
1.4 Endocannabinoid System (eCB) 
1.4.1  Endocannabinoid System Background 
The endocannabinoid system is composed of endocannabinoid ligands, 
cannabinoid receptors and synthetic and degradative enzymes. This system is involved 
in a variety of physiological processes such as mood, memory, pain, and appetite 
(reviewed by Mechoulam & Parker, 2013). The CB1 receptor was first cloned in 1990 




peripheral tissues, particularly spleen, soon after in 1993 (Munro, Thomas, & Abu-Shaar, 
1993). Both CB1 and CB2 receptors are G protein-coupled receptors (GPCR) that have 
similarly in 48% of amino acid sequence and couples to adenylyl cyclase and mitogen-
activated protein kinase (Howlett et al., 2002). CB1 receptors are mainly expressed in the 
central nervous system (CNS) and they are one of the most abundant GPCRs in brain 
(Howlett et al., 2002). As they are found on GABA and glutamatergic neurons, they are 
involved in GABA and glutamate neurotransmission (Howlett et al., 2002). Activation of 
CB1 receptors decreases cyclic adenosine monophosphate (cAMP) accumulation and 
this inhibits the cAMP-dependent protein kinase (PKA). Also, CB1R activation stimulates 
the mitogen-activated protein (MAP) kinase activity. In addition, CB1R are coupled 
through G proteins to many types of potassium and calcium channels. On the other hand, 
CB2 receptors are mainly present in the immune system and recently were found to be 
expressed at low levels in CNS (Ashton, Friberg, Darlington, & Smith, 2006; Onaivi et al., 
2008; Van Sickle et al., 2005). Similar to CB1, activation of CB2R inhibits cAMP 
accumulation through Gi/o proteins and hence decreases the MAP kinase activity (Felder 
et al., 1995; Kobayashi, Arai, Waku, & Sugiura, 2001). Moreover, CB2R activation results 
in activation of phospholipase C (PLC) and modulates the intracellular Ca2+ concentration 
(Zoratti, Kipmen-Korgun, Osibow, Malli, & Graier, 2003). In addition, there are also former 
orphan receptors that are now considered as cannabinoid receptors expressed in several 
peripheral systems and brain including G-protein coupled receptor 18 (GPR18), GPR55 
and GPR119. These formerly orphan receptors play a role in various physiological and 
disease conditions such as melanoma, pain, diabetes, obesity, and osteoarthritis (A. 




The endogenous cannabinoid ligands are lipids that bind to the cannabinoid 
receptors. These include most notably anandamide (AEA) and 2-arachidonoyl glycerol 
(2-AG, Figure 1.1). AEA was first identified by Mechoulam and his colleagues in 1992 
(Devane et al., 1992) while the 2-AG was first described in 1995 (Mechoulam et al., 1995). 
Both of those ligands are retrograde synaptic messengers and synthesized on demand 
and are degraded by different enzymes. Multiple biosynthetic pathways play roles in the 
synthesis of AEA and this includes enzymes such as Ca++-dependent N-acyltransferase 
(NAT) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD, (Wang & 
Ueda, 2009). AEA has a very short half-life (< 5 minutes) and is degraded by fatty acid 
amide hydrolase (FAAH) into arachidonic acid and ethanolamine (Cravatt et al., 2001). 
On the other hand, phospholipase C (PLC) and diacylglycerol lipase (DAGL) are involved 
in the 2-AG synthesis and formation while monoacylglycerol lipase (MAGL) is responsible 
for its degradation (Dinh et al., 2002). AEA has a low affinity for and is a partial agonist at 
both CB1 and CB2 receptors, however 2-AG has a high affinity (a full agonist) to CB1R 
and low affinity for CB2R (Gonsiorek et al., 2000; Luk et al., 2004). In addition, there are 
other ligands that may serve as endocannabinoids including N‐dihomo‐γ‐
linolenoylethanolamine, N‐docosatetra enoylethanolamine, O‐
arachidonoylethanolamine, oleamide, N‐arachidonoyl dopamine and N‐oleoyl dopamine  




1.4.2 Importance of Endocannabinoids (eCB) Signaling for Early CNS Development and 
Function  
Many studies have found that eCB signaling emerges and is operating at an early 
age. Autoradiography experiments show that CB1 receptor levels peak during 
developmental and decrease in the adult rat (Bossong & Niesink, 2010). CB1 receptors 
are distributed to different extents in different brain regions, such as the cerebellum, the 
hippocampus, the basal ganglia, and the cortex, which suggests a role in a number of 
physiological processes including memory, mood, appetite, and pain-sensation (Bossong 
& Niesink, 2010).  The use of cultured hippocampal neurons, it can be demonstrated that 
the activation of CB1 receptors located in presynaptic GABAergic neurons leads to the 
inhibition of GABA release (A. J. Irving et al., 2000). Axonal growth cones in GABAergic 
neurons are rich with CB1 receptors and endocannabinoids trigger the collapse of these 
cones (Watson, Chambers, Hobbs, Doherty, & Graham, 2008). These studies suggest 
that the eCB signaling has a critical role in early CNS development and function.  
1.4.3  Adolescent but not Adult Cannabinoid Exposure Leads to Persistent Changes in 
Behavior and Neurophysiology 
In one study, adolescent rats exposed chronically to THC showed a large deficit in 
their ability to learn. This effect was not seen when adults were exposed to the same 
treatments (Cha, Jones, Kuhn, Wilson, & Swartzwelder, 2007). Further experiments 
indicated that exposure to THC during development caused other persistent behavioral 
effects, such as affecting cognition and memory due to changes in hippocampal 




experiments suggest that adolescents are more vulnerable to behavioral and 
neurophysiological changes than adults. The mechanisms underpinning these effects are 
still poorly understood. In our lab using the zebra finch songbird model, exposure to 
cannabinoid agents during a critical period of CNS development (adolescence) resulted 
in similar effects (Soderstrom & Tian, 2006). Also, exposure to a cannabinoid agonist 
during development leads to elevations of dendritic spine densities in the basal ganglia 
(Area X) and HVC regions (Gilbert & Soderstrom, 2011).This indicates that the exposure 
to cannabinoid agonist disrupts the normal decrease of dendritic spine densities over the 
course of development (Gilbert & Soderstrom, 2011). 
1.5 Endocannabinoid System and Reward 
CB1 receptors are the most abundant G protein-coupled receptors in the brain and 
they are expressed in brain regions that are important for reward and addiction including 
NAc, ventral tegmental area (VTA), lateral hypothalamus, PFC, and amygdala (Glass, 
Faull, & Dragunow, 1997; X. Wang, Dow-Edwards, Keller, & Hurd, 2003). Activation of 
pre-synaptic CB1R inhibits neurotransmitter (e.g. GABA & glutamate and acetylcholine) 
release that have many effects on neuronal signaling. There is a body of evidence 
demonstrating that both opioid and dopaminergic systems are influenced by eCB 
signaling in the context of reward and reinforcement behaviors (Wenzel & Cheer, 2018). 
For example, opioids are rewarding because of their effects on the mesolimbic DA 
system. Opioids exert their effects such as analgesia, respiratory depression, and 
euphoria by binding to opioid receptors GPRCs (Gi/o) including mu opioid receptor 
(MOPR), delta opioid receptor (DOPR), and the kappa opioid receptor (KOPR). Those 




Therefore, in one study it was found that administration of MOPR agonist (including 
morphine and endorphins) produced conditioned rewarding effects (reviewed by 
Shippenberg, LeFevour, & Chefer, 2008). Much evidence shows that there are 
interactions between the eCB and opioid systems. For example, it has been found that 
exogenous THC administration results in releasing endogenous opioids (enkephalins) in 
the NAc (Valverde et al., 2001). Additionally, heroin self-administration was found to 
increase the extracellular levels of endocannabinoids (particularly, 2-AG levels) in the 
NAc shell (Caillé, Alvarez-Jaimes, Polis, Stouffer, & Parsons, 2007). Moreover, cross 
tolerance can occur as a result of chronic administration of either THC or opioid drugs 
(Newman, Lutz, & Domino, 1974). Further, the administration of either WIN 55,2121-2 (a 
CB1 receptor full agonist) or heroin led to alterations of the levels and activity of µ-opioid 
(MOR) and CB1-cannabinoid receptors (CB1R) in the PFC, NAc , caudate-putamen (CP) 
and other brain areas that mediate rewarding effects (Fattore et al., 2007). The 
mechanism behind the interaction between the eCB and opioid systems is still unclear. 
One explanation could be that the co-localization of the two systems in the brain regions 
that are responsible for the rewarding effects might play a role (Pickel, Chan, Kash, 
Rodríguez, & MacKie, 2004). Moreover, one study reported that CB1 cannabinoid and µ-
opioid (MOR) receptors in the NAc core may heterodimerize and synergistically inhibit 
GABA release (Schoffelmeer, Hogenboom, Wardeh, & De Vries, 2006).     
Also, CB1 and µ-opioid (MOR) receptor interaction meditate reward and 
reinforcement effects. This evidence shows the rewarding effects of THC are abolished 
in µ-opioid (MOR) knockout mice (Ghozland et al., 2002). In addition, another study 




cannabinoid-induced conditioned place preference, CPP (Braida, Pozzi, Cavallini, & Sala, 
2001). On the other hand, the absence of CB1 receptor blocked the opiate-induced CPP 
(Ledent et al., 1999). These data suggest that the interaction between eCB and opioid 
system may enhance and facilitate the DA release the brain reward areas.     
Moreover, exogenous AEA and 2-AG administration increases DA levels in the 
limbic system through a CB1R dependent mechanism (Solinas, Justinova, Goldberg, & 
Tanda, 2006). However, in most animal studies, neither a FAAH inhibitor nor a MAGL 
inhibitor administered alone increased the reward-related behaviors or drug 
reinforcement (Panlilio, Justinova, & Goldberg, 2013). However, concurrent 
administration of FAAH and MAGL inhibitors was found to increase self-administration, a 
result suggesting the need for a robust elevation of both AEA and 2-AG in order to result 
in a THC-like discrimination effects (Wiley et al., 2014; Wise et al., 2012).   
Other drugs of abuse such as alcohol, nicotine, opiates were found to alter the 
level of endogenous cannabinoids (AEA and 2-AG) in different brain regions which 
indicates their important role in the brain reward effects and addiction of these drugs 
(González et al., 2002; Simonnet, Cador, & Caille, 2013; Viganò et al., 2003). For 
example, evidence from in vivo microdialysis in the NAc after ethanol administration 
demonstrated an increasing level of extracellular 2-AG and with no effect on the level of 
AEA (Simonnet et al., 2013). However, opioid exposure increased the content of AEA 
and slightly decreased 2-AG concentrations (Simonnet et al., 2013). In addition, chronic 
nicotine exposure resulted in a reduction in the levels of both AEA and 2-AG in midbrain 
while it increased their levels in brainstem, and AEA only in the limbic forebrain (González 




2-AG in VTA (Buczynski, Polis, & Parsons, 2013). Moreover, reports of chronic opiate 
administration in rats demonstrated a reduction in the 2-AG levels without any alterations 
of AEA content in limbic brain regions and hypothalamus (Viganò et al., 2003). Moreover, 
a psychostimulant drug, such as methylphenidate, decreased the concentration of both 
AEA and 2-AG in the limbic forebrain of the mice (Patel, Rademacher, & Hillard, 2003). 
All of the previous examples indicate that many of the drugs of abuse alter the levels of 
endocannabinoids and sometimes produce similar or opposite effects on brain AEA and 
2-AG contents. The differences in the effects on the endocannabinoid levels in those 
studies could be due experimental differences such as drug route of exposure, duration 
of treatment, or dose of drug.  
1.6 Endocannabinoid System and Stress 
Interaction between the endocannabinoid system and hypothalamic-pituitary-
adrenal (HPA) axis is important in order to regulate stress responses. CB1R is highly 
expressed in brain regions that are important for HPA-axis regulation such as amygdala, 
hippocampus, hypothalamus and PFC (Herkenham et al., 1990, 1991). Activation of the 
HPA axis is known to be responsible for a stress response trigger. It starts when the 
activation of hypothalamus leads to release corticotropin-releasing factor (CRF). CRF 
binds and activates the anterior pituitary gland to release adrenocorticotropic hormone 
(ACTH). ACTH binds to adrenal receptors adrenal and stimulates release of cortisol 
(reviewed by Micale & Drago, 2018). CB1R is found to be expressed in hypothalamus, 
pituitary gland, and adrenal gland which suggests it may have a role in releasing CRF, 




may have a potential role for eCB system in stress response (reviewed by Micale & Drago, 
2018). 
1.6.1  Acute Stress  
Restraint stress was found to increase the level of FAAH, a degradative enzyme 
for AEA, and reduce the content of AEA in amygdala and hippocampus (Matthew N Hill 
et al., 2009; M. Wang et al., 2012) and this was in parallel with a higher level of 
corticosterone in blood (Matthew N Hill et al., 2009). In contrast, results from a foot shock 
paradigm demonstrated an increase in the level of AEA in mPFC, amygdala and 
hippocampus (Morena et al., 2014). These discrepancies could be explained by using 
different protocols (restraint stress vs foot shock paradigm) or by using different animal 
species (mice vs rats). Other studies showed an increase in the level of 2-AG in response 
to acute stress in different brain areas including the hypothalamus, hippocampus, and 
mPFC. In addition, higher levels of corticosterone were found to modulate 2-AG levels in 
the hypothalamus, hippocampus, and mPFC (Evanson, Tasker, Hill, Hillard, & Herman, 
2010; Matthew N. Hill et al., 2011; M. Wang et al., 2012). No changes in CB1 and CB2 
receptor expression or activity in brain were found following the restraint stress exposure 
(Matthew N Hill et al., 2009; MacDowell et al., 2017).             
1.6.2 Chronic Stress  
Chronic restraint stress was found to increase FAHH activity and reduce the level 
of AEA in brain areas such as hypothalamus, hippocampus, and amygdala (M N Hill et 
al., 2013). Also, it was found that corticosterone treatment decreases AEA content via 




mediated mechanism (Bowles et al., 2012). In contrast, using another model of chronic 
unpredictable stress (CUS) did not show any changes in the level of AEA (Bowles et al., 
2012; Gray et al., 2016). On the other hand, prolonged restraint stress increased the level 
of 2-AG in hypothalamus, hippocampus, amygdala and mPFC (Dubreucq et al., 2012; 
Patel, Roelke, Rademacher, & Hillard, 2005). In the context of the CB1R, chronic stress 
exposure reduced its expression and activity in striatum, hypothalamus, midbrain, 
hippocampus (Bortolato et al., 2007; Matthew N. Hill et al., 2008).  
1.7  Zebra Finch Songbirds as a Developmental Learning and Drug Abuse Model 
Zebra finch songbirds are naturally vocal learners, like humans: these birds 
provide advantages for studying drug effects during critical periods of learning. Zebra 
finch brain contains specialized song regions that are involved in song learning and 
production. There are two critical pathways for song learning and production. The song 
learning pathway known as the anterior forebrain pathway (AFP) is comprised of at least 
three regions: lateral magnocellular nucleus of the anterior neostriatum (lMAN); the basal 
ganglia (Area X) and the thalamic region DLM. These interconnected regions form a 
circuit that is important during the sensorimotor period of vocal learning. The other 
pathway is the song production pathway that contains most notably HVC and the robust 
nucleus of the archistriatum (RA). In addition, an auditory pathway comprised of CMM 
and NCM, interface with the motor circuit, that in turn influences the learning circuit 




1.8 Goal of Research and Statement of Hypothesis  
As described above, adolescence is a distinct and critical period of learning new 
skills such as language, motor behaviors, and social interaction. To the best of our 
knowledge, chronic Cannabis abuse during adolescence and its persistent effects though 
adulthood are not adequately investigated. Our model, zebra finch songbirds, because of 
their specific features and characteristics as discussed above compared to other animal 
models, were used in this project to address our questions that are related to chronic 
cannabinoid exposure. Previously in our lab, reported that chronic cannabinoid 
treatments during adolescence, not adulthood, causes: 1) alteration in the song learning 
ability (Soderstrom & Johnson, 2003) and; 2) persistently altered axonal and dendritic 
spine densities in zebra finch brain regions that are important for song (Gilbert & 
Soderstrom, 2011, 2014; Soderstrom, Poklis, & Lichtman, 2011). Also, acute cannabinoid 
treatments inhibited zenk and Arc/Arg3.1 expression in NCM, one of the auditory 
perception regions, which in turn affects song recognition (Gilbert & Soderstrom, 2013). 
However, it is still unclear whether endocannabinoid signaling is important during the 
critical period of drug reinforcement and song learning or not. Zebra finch song brain 
regions contain high level of CB1 receptors and 2-arachidonoyl glycerol (2-AG), and their 
levels change over the course of development (Soderstrom & Wilson, 2013). Preliminary 
evidence that CB1 receptor antagonism alters song in a manner similar to agonists 
suggests that this is the case, but it has not yet been experimentally confirmed.   
The goal of this research was to evaluate the chronic exposure of THC, the 
psychoactive constitute of Cannabis, during adolescence and how that can affect both 




the behavioral effects of Cannabis, the most widely abused drug by teenagers, and 
whether if it becomes a gateway drug for more toxic substances such as cocaine later in 
life. Moreover, the importance of endocannabinoid signaling to critical period-dependent 
learning will be investigated. 
This project will provide information to better understand the effects of 
developmental Cannabis exposure and the role of the endogenous cannabinoid signaling 
during a natural sensorimotor learning period.  Effects on vocal learning will be compared 
to changes in cocaine sensitivity later in life as a model of learning related to addiction. 
We suspect that similar neuronal circuits control development-dependent learning of both 
vocal communication and drug abuse. 
Specific Aims  
We investigated how developmental THC exposure (relevant to Cannabis abuse) 
and manipulation of the principal CNS endocannabinoid (2-AG) cause both persistently 
altered vocal learning and learning related to reinforcement. Both of these behavior 
effects may arise from similarly-altered neurophysiology involving the same neural 
circuits. To test this hypothesis, three aims were developed as follows: 
Aim 1: Determine if THC exposure during zebra finch sensorimotor vocal 
learning alters cocaine reinforcement through adulthood 
This aim evaluated chronic THC daily treatment for developmental and adult zebra 
finches prior to cocaine challenge tests. A conditioned place preference (CPP) paradigm 
similar to that used in rodents was used to evaluate drug reinforcement (Riters & 
Stevenson, 2012). First, the appropriate cocaine dose to be used for a songbird model in 




immunohistochemistry (IHC) for the expression of c-Fos as an indicator of neuronal 
activity in song brain regions was conducted in order to investigate their involvement in 
response to different cocaine doses. Second, the delayed time to introduce animal to CPP 
chambers was determined for cocaine preference or aversion behaviors. Third, persistent 
effects of chronic THC and nicotine treatments was evaluated.  
Aim 2: Determine if brain regions involved in endocannabinoid-altered drug 
reinforcement and vocal learning overlap  
This aim evaluated the role of 2-Arachidonoyl glycerol (2-AG), one of the 
endogenous cannabinoids, in drug reinforcement. First, developmental and adult animals 
were chronically treated with JZL-184 (selective MAGL inhibitor) in order to systemically 
increase the level of 2-AG prior to cocaine challenge using CPP. Moreover, different 
methods such as HPLC, mass spectrometry, IHC (for what protein?) were used to test 
the involvement of song brain regions in drug reinforcement.           
Aim 3: Does chronic activation of endocannabinoid signaling with an indirect 
agonist (JZL-184) mimic the effects of exogenous agonist (THC) on vocal learning? 
This aim focused on the effects of chronic THC and JZL-184 on song alteration in 
both developmental and adult zebra finches. Different software for song analysis was 
used after the chronic treatment and maturation. SAP2011 software helped us to 
characterize syllables with measures of 14 acoustic parameters and with song recording. 
In addition, Kullback-Leibler (KL) distances is a statistical method to compare the 2D 
probability distributions between different groups after chronic treatments was used. 
Other software programs such as Avisoft SASLab, Bulk Rename Utility, Spectrogram16 









Figure 1.1. Structures of the phytocannabinoids delta-9-tetrahydrocannabinol and 





(Adapted from Mechoulam and Parker 2013)
 
 
CHAPTER 2:  DELTA-9-THC EXPOSURE DURING ZEBRA FINCH SENSORIMOTOR 
VOCAL LEARNING INCREASES COCAINE REINFORCEMENT IN ADULTHOOD 
2.1 Introduction 
Zebra finches learn vocal patterns during a critical period of development (Eales, 
1985). Because of this they represent an animal model suitable for studying neurobiology 
underlying maturational stage-dependent learning ability (Mello, 2014). 
We have previously found that the critical period for vocal learning in these animals 
is associated with distinct sensitivity to CNS-active drugs (Soderstrom & Johnson, 2003).  
For example, exposure to a cannabinoid agonist during distinct sub-periods of 
sensorimotor vocal learning have differing effects on the relative numbers of syllables 
improvised vs. learned from adult male tutors (Soderstrom & Tian, 2004).  Thus, this 
songbird model is suitable for investigating effects of drugs to alter behavior (and 
underlying neural circuitry) dependent upon learning during distinct, sensitive periods of 
development. Ability to study naturally learned vocal behavior is a unique to songbirds 
and is not possible with more common rodent models. 
A missing feature of the zebra finch model is ability to study drug reinforcement of 
behavior (Spealman & Goldberg, 1978; Tzschentke, 1998). This is important as 
developmental exposure to multiple classes of abused drugs are associated with 
increased self-administration and sensitivity to reinforcement in adulthood (Linda Patia 
Spear, 2016) As drug exposures during similar periods of development cause both 
persistently-altered vocal learning and learning related to reinforcement, both may arise 




both types of learning within the same animal model. To fill this gap, we have developed 
methods to measure cocaine-conditioned reinforcement of place preference in zebra 
finches. The method we have employed is adapted from that described previously to 
demonstrate rewarding effects of undirected singing (Riters & Stevenson, 2012). 
We have used the resulting place preference method developed to test ability of 
both THC and nicotine administered during vocal learning periods to persistently alter 
cocaine reinforcement in adulthood. 
2.2 Materials and Methods  
2.2.1 Subjects 
Subjects were adult zebra finches raised in our breeding aviary. Both male and 
female animals were used as indicated. Birds were housed under 14:10-hr light/dark 
cycles and provided ad libitum food (Sun Seed VitaFinch) and water. 
2.2.2 Chemicals and Reagents 
Except where noted all supplies, chemicals and reagents were purchased from 
Sigma or Fisher Scientific. The phytocannabinoid partial agonist THC was obtained from 
the NIDA drug supply program. Drugs were suspended in vehicle for injections from 
concentrated DMSO stocks. 
2.2.3 Drug Treatments 
Drugs were delivered in 50 µl via IM injection into pectoralis using 30 ga needles. 




days. For developmental exposures, treatments were given from 50 – 75 days of age 
during a period of sensorimotor vocal learning. Following developmental treatments, 
animals were allowed to mature to adulthood at 100 days of age. For adult exposures, 
mature animals (>=100 days of age) were given 25 daily injections and were 
unmanipulated for an additional 25 days to simulate the maturation period in the 
developmental group. Following the maturation or simulated maturation period, animals 
underwent cocaine-reinforced place preference testing as described below. 
2.2.4 Place Preference Apparatus 
The place preference chambers used were constructed from two standard wire 16 
X 16 X 18” finch cages with right or left side panels removed. Cages were joined at the 
missing panels by steel cage rings. An opening for a removable panel was created 
between the two cages. This removable panel was constructed from stiff poster board 
with bright yellow construction paper glued to one side, and bright green construction 
paper glued to the opposing side. The same yellow or green construction paper was 
affixed with zip ties to the sides, roof and floor of respective cages. A standard wooden 
perch was used in one cage, and an aluminum foil-covered perch was used in the 
opposing cage. Thus, chambers were distinguished by color and perch texture. 
2.2.5 Cocaine-Conditioned Place Preference 
Experiments were conducted in the afternoon. During the first five days of 
experiments, the panel separating the two chambers of the place preference apparatus 
was removed and animals were allowed to freely explore both sides for a period of 15 




chamber that each animal spent the least amount of time in during these pre-conditioning 
tests was designated as the least-preferred chamber. For conditioning, the chamber-
dividing panel was installed, and animals were randomly assigned to receive cocaine or 
vehicle as their first treatment. Vehicle or cocaine injections were given IM and unless 
specified otherwise, animals were confined in a chamber 5 min after injections for a period 
of 15 min. Also, unless otherwise specified, animals receiving cocaine were placed in 
least-preferred chambers. Vehicle and cocaine treatments were made on alternating days 
for a total of eight days. The day following this conditioning period, animals were given a 
preference test by removing the dividing panel and allowing free exploration of both sides 
of the apparatus. The amount of time spent in the cocaine-paired chamber was 
determined and used to calculate a preference score (post-conditioning minutes spent in 
the cocaine-paired chamber minus pre-conditioning minutes spent in the cocaine-paired 
chamber). 
2.2.6 Cocaine Dose-Response Experiment 
To determine an appropriate dosage of cocaine to use in chronic treatment studies, 
a dose response experiment was done to evaluate efficacy of 0, 1.25, 2.5, 5 and 10 mg/kg 
dosages. Each group consisted of n = 6 animals. In an effort to ensure that some level of 
place preference was observed, half of the animals in each dosage group were assigned 
to receive cocaine in their least-preferred chamber (determined as described above) and 
the other half in their preferred chamber. Cocaine-conditioned place preference 
experiments were done as described above. For conditioning, animals were placed in the 




2.2.7 Anti-c-Fos Immunohistochemistry 
The day following post-cocaine conditioning preference tests, animals in the dose-
response experiment were killed by Equithesin overdose and PBS (pH = 7.4) followed by 
phosphate-buffered 4% paraformaldehyde, pH = 7.0 transcardially perfused.  After brains 
were removed and immersed overnight in buffered 4% paraformaldehyde, they were 
blocked down the midline, and hemispheres were sectioned parasagittally (lateral to 
medial) on a vibrating microtome. Immunohistochemistry was performed using a standard 
protocol reported in (Whitney, Soderstrom, & Johnson, 2000) except that anti-c-Fos 
primary antibody was employed. For immunohistochemistry experiments, 30-μm sections 
of zebra finch brain were reacted with a 1:3,000 dilution of polyclonal anti-c-Fos antibody 
raised in rabbit (Santa Cruz Biotechnology, cat #sc-253). Tissue sections were rinsed in 
0.1% H2O2 for 30 min, blocked with 5% goat serum for 30 min, and incubated overnight 
in blocking solution containing anti-c-Fos antibody (1:3,000). After antibody exposure, 
sections were rinsed in PBS (pH = 7.4), incubated in blocking solution containing 
biotinylated anti-rabbit antiserum (1:500) for 1 h, rinsed with PBS again, and then 
submerged in avidin–biotin–peroxidase complex solution (purchased as a kit from Vector 
Laboratories) for 1 h. Antibody labeling was visualized with DAB (diaminobenzidine) 
solution. Control sections that were not incubated in primary antibody were not 
immunoreactive. 
Staining was examined in various brain regions at 200X using an Olympus BX51 
microscope with Nomarski DIC optics. Images were captured using a Spot Insight QE 
digital camera and Image-Pro Plus software (MediaCybernetics, Silver Spring, MD, USA) 




corrected, converted to grey scale, and borders of brain regions traced manually. Two-
dimensional counts of labeled nuclei from images and areas enclosed within traced areas 
were determined without knowledge of treatment condition for each brain region of 
interest from five separate sections per animal using Image-Pro Plus software. Mean 
densities (within region counts of stained nuclei/area of the region) were compared across 
treatment group and brain region with a two-way ANOVA as described below. 
2.2.8 Timing of Opposing Cocaine Responses 
When studied in rodents, cocaine initially produces positive reinforcement shortly 
after administration that is later followed by a negative affective state (Ettenberg, 2004). 
Therefore, a complete characterization of cocaine reinforcement in our songbird model 
system depended upon understanding the timing of these responses in zebra finches. 
Zebra finches (n = 6) were randomly assigned to timing groups to receive 1, 5, 10, 15 and 
30-minute delays after cocaine injections before introduction to the least preferred 
chambers. As this study was not related to singing behavior that is only produced by male 
zebra finches, these experiments provided an opportunity to employ adult females (>= 
100 days of age).  
2.2.9 Chronic Treatment with THC and Nicotine 
Developing (50 +/- 3 days of age) and adult (> 100 days of age) animals were 
randomly assigned to subgroups (n = 7 - 8) to receive either vehicle, THC (3 mg/kg 
suspended in vehicle) or nicotine (0.4 mg/kg suspended in vehicle). The vehicle for THC 
was DMSO:Alkamuls EL-620 [Rhodia, Cranberry, NJ]:PBS, 18:1:1. The vehicle for 




Treatments were given by IM injection of 50 µl into pectoralis. Injections were made once 
daily, in the morning, over a period of 25 days. Following chronic exposures, developing 
animals were allowed to mature to adulthood (100 +/- 3 days of age). Adult animals 
underwent the same 25 days treatment regimen followed by 25 days of no manipulation 
to simulate the maturation period in developing birds. After the maturation period or its 
simulation, animals were evaluated for cocaine-reinforced place preference as described 
above. 
2.2.10 Statistics 
Results of the dose-response experiment were evaluated by 2-way ANOVA with 
cocaine dosage and chamber preference as main effects. Results of chamber placement 
delay experiments were evaluated by 1-way ANOVA with delay time as the main effect. 
Results of chronic treatment studies that compared vehicle and drug-treated groups were 
evaluated using two-tailed t-tests. Statistics were calculated using SigmaStat 3.1 software 
running on a Windows XP emulation. Means +/- standard error or 95 % confidence 
interval are reported as indicated. 
2.3 Results 
2.3.1 Cocaine Dose-Response 
A dose-response experiment was done to determine an appropriate cocaine 
dosage to employ in place preference experiments. Groups of six adult males were 
assigned to receive 0, 1.25, 2.5 or 5 mg/kg cocaine. Twelve animals received 10 mg/kg 




their preferred chamber, and in the other half cocaine was paired in their least preferred 
chamber. In pre-conditioning preference tests 65 % of animals preferred green chambers 
with standard wooden perches, 35 % preferred yellow with foil-covered perches. Birds 
demonstrated strong chamber preferences and spent an average of 82.2 +/-2.9 % of the 
total pre-conditioning exploration time in their preferred chamber. Results of the dose-
response experiment are summarized in figure 2.1. Two-way ANOVA indicated that both 
dosage and chamber preference had significant effects on preference scores without an 
interaction (dosage F [4,26] = 5.00, p = 0.004; chamber preference F [1,26] = 8.28, p = 
0.008; interaction F [4,26] = 2.22, p = 0.094). In the case of animals receiving cocaine in 
their preferred chambers, all cocaine dosages resulted in 99.3 +/-5.4 % of preference test 
time in preferred chambers (Figure 2.1A). In contrast, a clear dose-response relationship 
(variable slope EC50 = 2.55 mg/kg) was observed in animals that received cocaine in 
their least preferred chamber (Figure 2.1B). As the goal of chronic exposure experiments 
was to determine potential persistent changes in sensitivity to cocaine reinforcement, a 
dosage of cocaine that produces a partial response, liable to either increases or 
decreases following chronic treatments with THC and nicotine was necessary. Thus, the 
2.5 mg/kg cocaine dosage, paired with least preferred chambers, was employed in the 
following experiments. 
2.3.2 Timing of Opposing Cocaine Responses 
Similar to what is observed following IV administration of 0.75 mg/kg cocaine to 
rats (Ettenberg, 2004) we found that 2.5 mg/kg cocaine delivered IM resulted in place 
preferences when introduction to chambers was delayed 1, 5 or 10 min following 




ANOVA confirmed a significant effect of chamber placement delay on preference scores 
(F [4,25] = 3.61, p = 0.019). As our dose-response study employed a five minutes 
chamber placement delay following cocaine injections, for consistency we chose to 
continue to use this time in the subsequent experiments.  
2.3.3 Persistent Effects of Chronic THC and Nicotine Treatments 
In rats, nicotine administered during periadolescence, but not adulthood, 
persistently increases both nicotine self-administration (W Adriani, Macrì, Pacifici, & 
Laviola, 2002) and sensitivity to cocaine or diazepam reinforcement (McMillen et al. 2005; 
James-Walke et al., 2007) following maturation. Persistently-altered rodent behavior 
following adolescent exposure to multiple abused drug classes is established (reveiwed 
by Spear, 2016). To test the hypothesis that a similar phenomenon occurs in songbirds, 
we evaluated effects of periadolescent THC or nicotine treatments to persistently alter 
sensitivity to cocaine reinforcement. 
Animals (n=8) were treated once daily for 25 days with either vehicle, the 
cannabinoid partial agonist THC (3 mg/kg, in a DMSO-containing vehicle) or nicotine (0.4 
mg/kg, in an ethanol-containing vehicle). Groups of both developing (50 days of age) and 
adult (> 100 days of age) animals were compared. Following the 25-day treatment period, 
animals were allowed to mature without further treatment for an additional 25 days. Thus, 
at the time of cocaine conditioning, all animal were adults (>= 100 days of age) and any 
drug effects observed must have persisted for at least 25 days. Results of these chronic 
exposure experiments are summarized in figure 2.3.  
When administered during development, 3 mg/kg THC significantly increased 




(Figure 2.3A, difference between mean preference scores = 457.9, 95 % CI = 104.5 – 
810.5, p = 0.015, two-tailed t-test). No significant preference score differences were 
observed between vehicle- and THC-treated adults (Figure 2.3B, mean difference = 
162.1, 95 % CI =-292.6 – 616.8, p = 0.457, two-tailed t-test). These results suggest that 
developmental, but not adult THC treatments increases the sensitivity to the reinforcing 
effects of cocaine. This increased sensitivity is persistent, lasting at least 25 days. 
Seven adult animals were treated with nicotine, in all other groups n = 8. Although 
there was a trend for 0.4 mg/kg nicotine treatments delivered during development to 
increase preference scores for the cocaine-paired chamber, the difference from the 
vehicle group was not significant (Figure 2.3C, mean difference = 208.4, 95 % CI = -245.3 
– 662.2, p = 0.313, two-tailed t-test). Daily nicotine treatment of adults did not result in 
preference scores different from the vehicle-treated group (Figure 2.3D, mean difference 
= 27.5, 95 % CI = -462.4 – 517.8, p = 0.905, two tailed t-test). Although direct comparisons 
cannot be made across different experiments, preference scores in animals treated with 
the ethanol-containing vehicle used in the nicotine experiments (Vehicle, Figure 2.3C and 
D) appeared higher than those treated with the DMSO-containing vehicle in THC 
experiments (Vehicle, Figure 2.3A and B). These apparent differences may be due to 
aversive effects of the DMSO-containing vehicle or positive reinforcing effects of the 
ethanol-containing vehicle. Thus, the apparent lack of expected developmental nicotine 
efficacy to increase sensitivity to cocaine reinforcement may be related to elevated 




2.3.4 c-Fos Expression in Song Regions Following Preference Tests 
To begin to identify brain regions involved in learning cocaine reinforcement in 
songbirds, and to test the hypothesis that these regions may include those required for 
vocal learning (Figure 2.4), we assessed c-Fos expression as a function of cocaine 
dosage used for conditioning. Expression of c-Fos was induced by placement of animals 
back into their cocaine-conditioned chambers on the day following final preference tests. 
Neither drug nor vehicle were injected so that any response was a reaction to placement 
in the environment.  As expected, we observed high-level expression in striatum that 
receives prominent midbrain dopaminergic input. Less expected were the lowest 
expression levels in the striatal sub-region, Area X, and relatively low activity in a second 
nucleus of the learning-essential anterior forebrain pathway, lMAN. The vocal motor-
related cortical-like areas HVC and RA also showed clear dose-dependent sensitivity to 
cocaine. Statistics summarizing cocaine effects on c-Fos expression, and post-hoc 
comparisons of dosage groups to vehicle controls by brain region are presented in Table 
2.1. 
2.4 Discussion 
Consistent with effects observed in other vertebrates, cocaine dose-dependently 
conditioned a place preference in zebra finches, with a potency similar to what is 
characteristically-produced in rodents (Jones and McMillen, 1995; Mueller and Stewart 
2000). In addition, initial reward followed later by an opposing aversive response was 
observed over a time frame similar to that reported in rats (Ettenberg, Fomenko, 




Taken together, these results support the validity of the procedure we have developed to 
study cocaine reinforcement of songbird behavior.  
2.4.1 Persistent Effects of Developmental Drug Exposure in Songbirds 
We previously employed zebra finches as a vocal learning model to study effects 
of CNS-active drugs administered during late post-natal development. These songbirds 
have the advantage of natural learning vocal patterns during a sensitive period of late-
postnatal development that approximates mammalian adolescence. Repeated 
cannabinoid agonist exposure during the sensorimotor stage of vocal learning reduces 
the stereotypy of song motifs and the number of distinct note types produced in adulthood 
(Soderstrom and Johnson, 2003). Agonist exposure during this learning period also 
resulted in persistent changes to increase dendritic spine densities and expression of 
synaptic markers - physiological effects similar to those reported following developmental 
drug exposure in mammals (Gilbert & Soderstrom, 2014). Our current results contribute 
to this prior work by the demonstration of developmental cannabinoid exposure that not 
only alters vocal learning, but also persistently increases sensitivity to cocaine 
reinforcement. This is important as the same neural circuitry may control both. 
For example, the activation of dopaminergic projections from mammalian VTA to 
dorsal striatum is well known to be important to drug reward (Krebs, Boehler, Roberts, 
Song, & Woldorff, 2012). This circuit shares features with songbird midbrain projections 
to Area X (a region of basal ganglia). Positive reinforcement of singing behavior that is 
dependent upon this circuit is important to the process of vocal learning (Hoffmann, 
Saravanan, Wood, He, & Sober, 2016). Optogenetic activation of this songbird 




2018). Thus, the same neurodevelopmental changes responsible for altered vocal 
learning may also increase sensitivity to cocaine reinforcement. The songbird model 
represents a uniquely useful system with which to study such potential convergent 
developmental effects on a naturally learned, reward-dependent behavior.  
An unexpected result of this study was the inability to clearly document an effect 
of developmental nicotine exposure to increase cocaine sensitivity. Similar nicotine 
treatment during rat development clearly increases cocaine reinforcement in adulthood 
(McMillen et al., 2005). A  toward such an effect in zebra finches may indicate that 
increasing group sizes will confirm an effect. However, it may be the case that songbirds 
are less sensitive to cholinergic modulation than are rodent species. The apparently 
higher sensitivity to effects of THC during development may be related to distinctly high 
level CB1 receptor expression in relevant brain regions that notably peak during 
sensorimotor vocal learning (Soderstrom & Tian, 2006). 
2.4.2 Persistent Developmental Effects of Reinforcing Drugs 
The songbird drug reinforcement procedure we employed here is based on that 
developed by (Riters & Stevenson, 2012), that was used to demonstrate that singing is 
rewarding to these animals. We are not the first to have used an avian species to study 
drug reinforcement. Pigeons have long been used in operant conditioning experiments, 
and reinforcing effects of both THC (Dykstra, McMillan, & Harris, 1975; Henriksson, 
Johansson, & Järbe, 1975) and cocaine (Evans & Wenger, 1990) were evaluated in these 
semi-terrestrial birds. To the best of our knowledge, however, the current report 
documents the first use of avian reinforcement to evaluate persistent effects of chronic, 




of drug abuse is associated with increased probability of addiction and dependence 
throughout life (Hingson, Heeren, & Winter, 2006; Mechoulam et al., 1995). In rodent 
models, adolescent exposures to several classes of CNS active drugs are associated 
with persistent increases in reinforcement and self-administration (reviewed by Spear, 
2016). For example, in the case of nicotine, repeated injections for 10 days during 
adolescence increase both nicotine self-administration (W Adriani et al., 2002) and 
cocaine reinforcement (McMillen et al., 2005). These drug abuse-relevant behavioral 
changes are only produced following exposures during distinct, sensitive periods of 
development and persist to adulthood – similar to the sensitive period of zebra finch vocal 
learning. 
2.4.3 Brain Regions Involved 
Comparative studies employing non-mammalian species hold promise in revealing 
the extent to which persistent effects of developmental drug exposures have been 
conserved over the course of evolution. To date, few such studies have been done. Our 
results demonstrating songbirds can be used to study drug-reinforced place-preference 
represent one of the first steps toward addressing this gap. Distinct changes in neuronal 
activity as indicated by changes in c-Fos expression suggest that brain regions important 
to vocal learning (Area X and lMAN) and motor production (HVC and RA) are also 
involved in cocaine-induced place preference. Evidence for cocaine-related increases in 
neuronal activity within songbird striatum is consistent with effects observed in rats 
(Graybiel, Moratalla, & Robertson, 1990). Higher sensitivity to these c-Fos expression 
effects within vocal motor regions (HVC and RA) relative to that within the learning-




dopaminergic projection from midbrain A11-type neurons to drive activity in HVC 
(Hamaguchi & Mooney, 2012).  
Because chronic, developmental exposure to THC persistently increased 
sensitivity to cocaine reward in adulthood, increased activity of dopaminergic midbrain to 
striatal projections important to reward are likely involved. This is a hypothesis that should 
be tested and suggests that cocaine sensitivity involves altered development of the VTA 
to Area X/basal ganglia projection responsible for vocal-learning-related reinforcement of 
singing behavior. Thus, the songbird model promises to allow determination of the extent 
to which development altered by CNS drug exposure may generally impact all learning 
that is dependent upon intrinsic reinforcement. 
2.5 Conclusion 
We have developed a songbird model to study drug-reinforced place preference. 
This model has allowed us to demonstrate that songbird behavior is reinforced by cocaine 
in a manner consistent with rodent species. Use of this model has also allowed us to 
determine that exposure to THC during periods of sensorimotor vocal learning 
persistently increases sensitivity to cocaine in adulthood. Because vocal learning and 
drug reinforcement involve similar dopaminergic projections from midbrain to ventral 
striatum, the songbird model provides an opportunity to study how developmental drug 
































Figure 2.1. Cocaine dose-dependently reinforces place preference in zebra 
finches 
Groups were assigned to receive 0, 1.25, 2.5, 5 or 10 mg/kg cocaine (n = 6 - 12). 
Significant effects of both cocaine dosage and pre-treatment chamber preference were 
confirmed by 2-way ANOVA (p = 0.004 and 0.008, respectively). A, animals that received 
cocaine within most preferred chambers spent greater than 99% of post-conditioning 
preference test time in those chambers. B, animals administered cocaine in least 










Figure 2.2. Cocaine produces both positive- and negative reinforcement of place 
preference 
 The valence of opposing responses depends upon the duration of intervals 
between cocaine injection and placement into least-preferred chambers (1-way ANOVA, 










Figure 2.3. THC (3 mg/kg, A and B) but not nicotine (0.4 mg/kg, C and D) increases 
sensitivity to cocaine when delivered during a sensitive period of vocal learning, 
but not in adulthood 
Daily treatments were administered for 25 days from 50-75 days in developing 
animals (A and C) or to adults (>= 100 days, B and D). Animals were allowed to mature 
an additional 25 days following treatments to adulthood. Animals in the adult treatment 
group were not manipulated for 25 days post-treatment to simulate the maturation period 
of the developmental group. Different vehicles were used for THC and nicotine (DMSO- 
and ETOH-containing, respectively). A potential increased cocaine sensitivity in the 
control animals treated with the ETOH-containing vehicle during development may have 









Figure 2.4. Examples of anti-c-Fos immunohistochemistry staining quality and 
spatial relationships between song regions of interest 
A, 12.5 X image of a 30 µm parasagittal section from about 2 mm lateral of the 
midline. Rostral is left, dorsal is up. Bar = 1 mm. Insets correspond to 100 X images: 
upper left, lMAN in panel C; lower left, Area X in panel D, upper right, HVC in panel E; 
lower right RA in panel F. 100 X bars = 100 µm. B, neurolucida-type tracing of 12.5 X 
image presented in panel A illustrating spatial relationships of song regions studied (black 







CHAPTER 3: CONTRASTING REWARDING AND AVERSIVE RESPONSES TO 
COCAINE REINFORCEMENT FOLLOWING DEVELOPMENTAL EXPOSURE TO 
DELTA-9-THC (THC) AND THE MAGL-INHIBITOR (JZL-184) 
3.1  Introduction 
We previously developed a CPP paradigm using zebra finches to study drug 
reinforcement (Chapter 2). Songbirds, like the zebra finch, are notable in that they learn 
a form of vocal communication during sensitive periods of development (Eales, 1985). 
Early developmental exposure to cannabinoid agonists persistently alter song patterns 
produced in adulthood (Soderstrom & Johnson, 2003). In addition, exposure to a 
cannabinoid agonist during development led to elevation of dendritic spine densities in 
the basal ganglia (Area X) and HVC regions (Gilbert & Soderstrom, 2011). This indicated 
that the exposure to cannabinoid agonist disrupts the normal decrease of dendritic spine 
densities over the course of development (Gilbert & Soderstrom, 2011). In a study where 
a rat model was used, Schneider and her colleagues found that enhancing the CB1R, by 
induction with a missense mutation when a single nucleotide is replaced by another one 
in the DNA sequence of the rat Cnr1 gene during adolescence, resulted in an adolescent-
like phenotype during adulthood (Schneider et al., 2015). This behavior was characterized 
by enhanced impulsivity, high risk seeking, increasing the reward sensitivity for drug and 
non-drug needs:  all indicating that the eCB activity plays an important role in mediating 
the adolescence behaviors (Schneider et al., 2015). More recently we have found that 
early exposure to THC increases cocaine sensitivity in a persistent manner that lasts 




was not seen in adults treated for the same period of time. This suggested that the brain 
regions responsible for vocal learning were also involved in long-lasting changes in drug 
reinforcement, supporting the hypothesis that early drug exposure may generally alter 
learned behaviors in a persistent manner that lasts throughout life.    
The current study extends results obtained with the exogenous cannabinoid 
agonist (THC) to establish effects of augmenting endocannabinoid signaling with the 
MAGL inhibitor (JZL-184) that acts as an indirect agonist by enhancing the level of the 
endogenous cannabinoids, 2-AG, that binds and activates the CB receptors. The 
hypothesis was that enhancing endocannabinoid signaling with JZL-184 would produce 
cocaine sensitization similar to that observed with THC. Interestingly, this hypothesis was 
not confirmed, and developmental JZL-184 treatments produced a persistent aversive 
response to cocaine in adulthood. These results suggest a more selective regional activity 
of endocannabinoid-related activity relative to the global cannabinoid receptor activation 
caused by exogenous agonist. In other words, JZL-184 may exert its effects in brain 
regions where there is tonic eCB signaling activity whereas THC will affect the entire 
brain. Comparisons of the patterns of neuronal activity associated with THC and JZL-184 
treatments will provide insight to brain regions responsible for distinct efficacy.  
The zebra finch model is well established for studying neurobiological changes 
underlying a naturally learned behavior that is dependent upon successful progress 
through a sensitive period of development. This learning requires activity of a basal 
ganglia-thalamocortical circuit termed the anterior forebrain pathway (AFP, that includes 
Area X → Dlm → lMAN → RA, Figure 3.10). Notably, Area X receives prominent 




from mammalian VTA to ventral striatum (Person, Gale, Farries, & Perkel, 2008). This is 
evident from effects of 6-OHDA lesions of dopaminergic terminals within Area X that 
greatly impair vocal learning, but have no detectable effect on vocal production (Hoffmann 
et al., 2016). Moreover, direct optogenetic activation of dopaminergic VTA projections to 
Area X improve vocal learning while inhibition impairs it (Xiao et al., 2018). Importantly, 
singing behavior itself is rewarding, as is evident in from the fact males singing undirected 
song develop a place preference to where singing was done consistent with striatal DA 
release (Riters & Stevenson, 2012). Singing-induced reward is evidence that both singing 
behavior and drugs produce reinforcement through similar mechanisms and suggests 
that all forms of incentive learning may involve the same basal ganglia-thalamocortical 
circuitry. 
Thus, the mechanism that is responsible for the drug reinforcement for either 
reward or negative emotions in zebra finch model after chronic developmental 
cannabinoid exposure is not known. It is important to study the neurobiological changes 
in the brain regions, that are responsible for song learning and production, if they are 
involved in drug reinforcement. If not, we will investigate the involvement of other brain 
areas such as TnA of amygdala, which is known for its role in negative emotions, and 
striatum for its association with the reward effects.   
Here, we tested the effect of chronic developmental THC and JZL-184 on drug 
reinforcement later in life using a CPP paradigm. Moreover, we measured the c-Fos 
expression, DA & DOPAC levels, and the content of AEA and 2-AG in brain regions that 
are important for vocal learning and production.   





Subjects were zebra finch songbirds that were bred in our aviary at East Carolina 
University. Juvenile zebra finches were removed to separate cages that contained adult 
tutors who already have characterized songs. The juvenile birds were in visual and 
auditory contact with the adult tutors from the age of 33-50 days. After that, they were 
removed from the tutoring cages and assigned to different treatment groups. During 
experiments, juveniles were housed singly in visual isolation with free access to grit, 
water, mixed seeds (Sunseed Vita Finch), and cuttlebone, and provided multiple perches. 
Animals were maintained on a 14:10 light/dark cycle, and ambient temperature was 
maintained at 78 F. All experiments were conducted based on protocols approved by East 
Carolina University’s Animal Care and Use Committee. 
3.2.2 Chemicals and Reagents 
Cocaine hydrochloride and paraformaldehyde were purchased from Sigma-Aldrich 
(St. Louis, MO). The phytocannabinoid partial agonist THC was obtained from the NIDA 
drug supply program. Equithesin was prepared from reagents (40% propylene glycol, 
10% ETOH, 5% chloral hydrate, 1% pentobarbital). Immunochemicals were purchased 
from Vector Laboratories (Burligame, CA). The primary c-Fos polyclonal antibody was 
purchased from Santa Cruz Biotechnology (Santa Cruz, California). MAG Lipase inhibitor 
(JZL-184) was purchased Cayman Chemical (Cyman, Michigan). Alkamuls EL-620 was 
a generous gift from Rhodia (Cranberry, NJ). DMSO and sucrose were purchased from 
Fisher Scientific (Pittsburgh, PA). Prism data analysis software was purchased from 




3.2.3 Drug Treatments 
Different treatments, such as THC 3 mg/kg, JZL-184 4 mg/kg, and cocaine 2.5 
mg/kg were used. THC and JZL-184 were diluted from concentrated DMSO or ethanol 
stocks and suspended in a vehicle to produce saline: DMSO/ethanol: Alkamuls EL-620, 
18:1:1. Cocaine was dissolved in saline [pH = 7].  50 μl of drug solutions were injected 
intramuscularly in the pectoralis muscle. For chronic exposures, injections were given 
once daily in the morning for a period of 25 days. For developmental exposures, 
treatments were given from 50 – 75 days of age during a period of sensorimotor vocal 
learning. Following developmental treatments, animals were allowed to mature to 
adulthood at 100 days of age. Following the maturation or simulated maturation period, 
animals underwent cocaine-reinforced place preference testing as described below. 
3.2.4 Place Preference Apparatus 
The place preference chambers used were constructed from two standard wire 16 
x 16 x 18-inch finch cages with right or left side panels removed. Cages were joined at 
the missing panels by steel cage rings. An opening for a removable panel was created 
between the two cages. This removable panel was constructed from stiff poster board 
with bright yellow construction paper glued to one side, and bright green construction 
paper glued to the opposing side. The same yellow or green construction paper was 
affixed with zip ties to the sides, roof and floor of respective cages. A standard wooden 
perch was used in one cage, and an aluminum foil-covered perch was used in the 




3.2.5 Conditioned Place Preference (CPP) Test  
Experiments were conducted in the afternoon. During the first five days of 
experiments, the panel separating the two chambers of the place preference apparatus 
was removed and animals were allowed to freely explore both sides for a period of 15 
min. Behavior was video recorded and time spent in each chamber documented. The 
chamber that animals spent the least amount of time in during these pre-conditioning 
tests was designated as the least-preferred chamber. For conditioning, the chamber-
dividing panel was installed, and animals were randomly assigned to receive cocaine or 
vehicle as their first treatment. Vehicle or cocaine injections were given IM and unless 
specified otherwise, animals were confined in a chamber 5 min after injections for a period 
of 15 min. Also, unless otherwise specified, animals receiving cocaine were placed in 
least-preferred chambers. Vehicle and cocaine treatments were made on alternating days 
for a total of eight days. The day following this conditioning period, animals were given a 
preference test by removing the dividing panel and allowing free exploration of both sides 
of the apparatus. The amount of time spent in the cocaine-paired chamber was 
determined and used to calculate a preference score (post-conditioning minutes spent in 
the cocaine-paired chamber minus pre-conditioning minutes spent in the cocaine-paired 
chamber). 
3.2.6 Immunohistochemistry Experiments 
The day following post-cocaine conditioning preference tests animals were killed 
by Equithesin overdose and PBS (pH = 7.4) followed by phosphate-buffered 4% 




immersed overnight in buffered 4% paraformaldehyde, they were blocked down the 
midline, and hemispheres were sectioned parasagittally (lateral to medial) on a vibrating 
microtome. Immunohistochemistry was performed using a standard protocol reported in 
(Whitney et al., 2000) except that anti-c-Fos primary antibody was employed. For 
immunohistochemistry experiments, 30-μm sections of zebra finch brain were reacted 
with a 1: 3,000 dilutions of polyclonal anti-c-Fos antibody raised in rabbit (Santa Cruz 
Biotechnology, cat #sc-253). Tissue sections were rinsed in 0.1% H2O2 for 30 min, 
blocked with 5% goat serum for 30 min, and incubated overnight in blocking solution 
containing anti-c-Fos antibody (1: 3000). After antibody exposure, sections were rinsed 
in PBS (pH = 7.4), incubated in blocking solution containing biotinylated anti-rabbit 
antiserum (1:500) for 1 h, rinsed with PBS again, and then submerged in avidin–biotin–
peroxidase complex solution (purchased as a kit from Vector Laboratories) for 1 h. 
Antibody labeling was visualized with DAB solution. Control sections that were not 
incubated in primary antibody were not immunoreactive. 
Staining was examined in various brain regions at 200X using an Olympus BX51 
microscope with Nomarski DIC optics. Images were captured using a Spot Insight QE 
digital camera and Image-Pro Plus software (MediaCybernetics, Silver Spring, MD, USA) 
under identical, calibrated exposure conditions. These images were background-
corrected, converted to grey scale, and borders of brain regions traced manually. Two-
dimensional counts of labeled nuclei from images and areas enclosed within traced areas 
were determined without knowledge of treatment condition for each brain region of 




densities (within region counts of stained nuclei/area of the region) were compared across 
treatment group and brain region using one-way ANOVA as described below. 
3.2.7 HPLC Analysis 
The day following post-cocaine conditioning preference tests animals were killed 
by Equithesin overdose. Brains were removed and placed on a cold glass plate. 
Microdissection of the VTA and Area X was done using the Palkovits punch technique as 
described in Charlier, 2010 and Vockel, Balthazart, 1990. Collected tissues were frozen 
over dry ice and stored at -80 for high performance liquid chromatography (HPLC) 
analysis. HPLC was used to determine the levels of DA and its metabolites, DOPAC. The 
internal standard utilized was 3,4-dihydroxybenzylamine (DHBA). Tissue was thawed on 
ice, weighed, and placed into homogenizing tubes containing 0.8 ml of 0.4 N perchloric 
acid + 50 ng DHBA. Tissue was then homogenized (Eberbach Con-Torque Homogenizer, 
Ann Arbor, MI, USA) and transferred to clean, labeled microcentrifuge tubes. An alumina 
extraction was performed, and extracted samples and standards were injected into a 
high-performance liquid chromatography system equipped with a Coulochem 5100A 
carbon electrode detector and a Brownlee Velosep Column (ESA, Bedford, MA, USA and 
RP-18, 3 mm, Shelton, CT, USA, respectively). The mobile phase for high performance 
liquid chromatography consisted of a 0.1 M potassium phosphate buffer, containing 0.10 
mM disodium-EDTA, 2.10 mM sodium octyl sulfate (SOS), 9% methanol, pH established 




3.2.8 Determination of Anandamide (AEA) and 2-Arachidonylglycerol (2-AG) Content 
Following developmental exposure, birds were allowed to mature to adulthood 
(100 days of age) prior the cocaine challenge experiments and then euthanized.  Brains 
were removed rapidly to a glass plate on dry ice and dissected to punch the areas of 
interest including Area X of striatum, Nucleus Taenea of amygdala (TnA), and the VTA. 
Tissues were frozen and stored at -80°C until extracted. On extraction day, tissues were 
homogenized in and extracted with chloroform:methanol:Tris-HCl 50 mM, pH = 7.5, 2:1:1, 
(v/v) containing internal standards (10 pmol of anandamide-d8, and 100 pmol of 2-
arachidonyl glycerol-d8, obtained from Cayman Chemicals). The lipid-containing organic 
phase was collected and dried under nitrogen. Samples were reconstituted in 100 μL of 
10:90 (v/v) water:methanol and placed in autosampler vials for analysis. The electrospray 
ionization-mass spectrometry-mass spectrometry (LC-ESI-MS-MS) method was used to 
detect and quantitate AEA and 2-AG.  
3.2.9 Statistics 
One-way analysis of variance (ANOVA) was used for experiments employing three 
or more treatment groups. Post-hoc analysis of ANOVA results was made with Newman-
Keuls post-tests, where appropriate. Student’s t-test was used for experiments employing 






3.4.1 JZL-184 Increases the 2-AG Level 
Adult animals (n = 3) were treated IM with either vehicle or indirect endogenous 
agonist JZL-184 (4 mg/kg, in a DMSO-containing vehicle). A trend for an increased 
concentration of the level of 2-AG was observed in JZL-184-treated animals compared to 
vehicle-treated group.   A t-test was conducted to compare between groups. (Figure 3.1. 
mean difference = 200.3, 95 % CI =-74.68 - 475.7, p = 0.11) 
3.4.2 Persistent Effects of Chronic THC and JZL-184 Treatments 
Animals (n = 8 - 24) were treated once daily for 25 days with either vehicle, the 
cannabinoid partial agonist THC (3 mg/kg, in a DMSO-containing vehicle) or indirect 
endogenous agonist JZL-184 (4 mg/kg, in a DMSO-containing vehicle), SR (6 mg/kg). 
Groups of developing (50 days of age) and adults (>= 100 days of age) were recruited. 
Following the 25-day treatment period, animals were allowed to mature without further 
treatment for an additional 25 days. Thus, at the time of cocaine-induced conditioning, all 
animal were adults (100 days of age) and any drug effects observed must have persisted 
for at least 25 days. Results of these chronic exposure experiments are summarized in 
figure 3.2. When drugs were administered during development, one-way ANOVA 
confirmed a significant effect of treatments on preference scores (F [5,73] = 10.34, p < 
0.0001). Newman-Keuls post-tests revealed significant increases in mean preference in 
THC-treated animals (from 248.4 ± 182.2 sec to 672 ± 34.47 sec, p < 0.05) and decreases 
in mean preference in JZL-184 treated animals (from 248.4 ± 182.2 sec to -138.1 ± 54.88 




3.4.3  No Effect of Chronic JZL-184 Treatment in Adults  
No significant preference score differences were observed between vehicle- and 
JZL-184 treated adults (Figure 3.3, mean difference = 177, 95 % CI =-325.6 – 697.6, p = 
0.462, two-tailed t-test). These results suggest that developmental, but not adult, JZL-184 
treatments cause aversion to the reinforcing effects of cocaine. This aversion is 
persistent, lasting at least 25 days. Earlier work showed that chronic THC treatment in 
adult has no effect compared to vehicle-treated group.   
3.4.4  Dopamine and Its Metabolites Levels Following Preference Tests 
DA levels were found to be elevated in the NAc in rats that developed conditioned 
place preference (Duvauchelle et al., 2000). To test the hypothesis that the mesolimbic 
DA system is involved in the cocaine preference effect after chronic developmental 
treatment, we assessed DA and DOPAC levels as a function of treatments (see Figure 
3.4 & 3.5). The mesolimbic DA system in zebra finches consists of DA pathways that 
originate in the VTA and terminate in Area X and HVC. In THC-treated animals, both DA 
and DOPAC levels were induced by placement of animals back into their cocaine-
conditioned chambers on the day following the final preference tests in Area X, and only 
DA levels in VTA. Although the concentration of DOPAC was higher in the VTA, the 
greater variability did not allow for significance.  This increase in DA and DOPAC levels 
was not seen in JZL-184 treated animals. As expected, we observed high-levels of DA 
and DOPAC content in the striatum that receives prominent midbrain dopaminergic input 
in THC-treated animals. These results suggest that chronic developmental THC treatment 




3.4.5 c-Fos Expression in Song Regions Following Preference Tests 
To begin to identify brain regions that are involved in learning cocaine 
reinforcement and aversion in songbirds, and to test the hypothesis that these regions 
may include those required for vocal learning, we assessed c-Fos expression as a 
function of treatments used for conditioning. Expression of c-Fos was induced by 
placement of animals back into their cocaine-conditioned chambers or vehicle-
conditioned chambers on the day following final preference tests. As expected, we 
observed high-level expression in striatum (Area X) that receives prominent midbrain 
dopaminergic input in THC treated animals. While we observed high-level expression in 
TnA (avian analog of amygdala) in JZL184-treated animals. The amygdala is a part of the 
limbic structure that plays a major role in a variety of physiological processes such as 
emotions (fear and anxiety), memory, and decision making (Amunts et al., 2005) . These 
results might explain the cocaine reinforcement in THC-treated animals and cocaine 
aversion in JZL-184 treated animals.  
In THC-treated animals, one-way ANOVA confirmed a significant effect of 
treatments on expression of c-Fos in the Area X region (F [3,56] = 18.51, p < 0.0001) 
followed by Newman-Keuls post-tests. Results of experiments in THC-treated animals 
are summarized in figure 3.5. In JZL-184 treated animals, one-way ANOVA confirmed a 
significant effect of treatments on expression of c-Fos in TnA of the amygdala region (F 
[3,56] = 11.45, p < 0.0001 followed by Newman-Keuls post-tests). Results of experiments 





3.5.1 JZL-184 Increased the Level of 2-AG  
one goal of this study was to investigate whether increasing the level of 
endogenous cannabinoid, particularly 2-AG because it is found in higher concentration 
compared to other endogenous cannabinoids in brain (Soderstrom et al., 2011), would 
result in effects similar to that of the exogenous cannabinoid THC. Thus, we injected 
animals with the indirect acting cannabinoid agonist JZL-184 in order to increase the 2-
AG content in brain. JZL-184 is a selective blocker of monoacylglycerol lipase (MAGL), 
the enzyme that is responsible for 85 % of 2-AG degradation (Long et al., 2009). Animals 
were euthanized 20 minutes after injections and the concentration of 2-AG was measured 
by mass spectrometry. We found that the concentration of 2-AG was elevated to double 
amount compared to the vehicle group. This result is consistent with what Long and his 
colleagues found when using 4 mg/kg of JZL-184: increased levels of 2-AG 30 minutes 
following injections (Long et al., 2009).    
3.5.2 Persistent Effects of Chronic THC and JZL-184 Treatments 
In harmony with our previous work, developmental THC treatment increased 
cocaine sensitivity later in life, during adulthood. To further understand the role of 
endocannabinoids, we manipulated the endogenous cannabinoid by treating animals with 
MAGL inhibitor JZL-184. Treating developing animals with JZL-184 during the sensitive 
period of vocal learning (50-75 days) resulted in conditioned place aversion to cocaine 
weeks later in adulthood. This persistent effect was not seen following similar treatment 




what was found in other studies. For example, in mice, an increased level of 2-AG in the 
basolateral nucleus of the amygdala (BLA) induced by systemic JZL-184 treatment 
promoted conditioned-fear (Llorente-Berzal et al., 2015). Another study showed that the 
impairment in fear extinction after JZL-184 administration was mediated by CB1 receptors 
expressed on GABAergic neurons (Llorente-Berzal et al., 2015). Thus, these results 
suggested that THC may enhance the DA signaling in striatum (Area X) which is 
associated with the reward emotions similar to the other drug of abuse while JZL-184 
exposure may lead to the augmentation of the tonically active endocannabinoid signaling 
in brain regions that are associated with negative emotions. Moreover, pre-treatment with 
SR before administration of THC and JZL-184 blocked their effects and suggested that 
the preference and aversion effects caused by THC and JZL-184 were both mediated by 
the CB1 receptor.    
3.5.3 Mesolimbic Pathway and DA Levels 
Most CNS active drugs that induce conditioned place preference exert their actions 
by increasing the synaptic level of DA in the limbic system structures, including the 
nucleus accumbens. In one study, repeated administration of cocaine to male Sprague–
Dawley rats in a distinctive environment had led to place preference for the cocaine paired 
compartment and increased the level of DA in NAc (Duvauchelle et al., 2000). Acute THC 
administration was found to increase the level of DA in the human striatum (van Hell et 
al., 2012), PFC (Pistis et al., 2002), and NAc (Chen et al., 1990). Moreover, repeated 
THC administration resulted in increase in the level of DA in the shell of the NAc (Tanda, 
Pontieri, & Di Chiara, 1997). To the best to our knowledge, there is a lack of studies that 




DA system. In our current study, we found that developmental THC exposure increased 
cocaine sensitivity, and this was associated with the increase in the DA and DOPAC 
levels in both VTA and Area X. An increase in both the transmitter and metabolite 
suggests that an increase in synthesis and turnover of DA occurred as a result of the 
exposure to the cocaine-paired environment by the THC-exposed birds.  The 
dopaminergic neuron transmission from midbrain to ventral striatum has been found to 
be important for drug reward (Krebs et al., 2012), and vocal learning in zebra finches 
(Hoffmann et al., 2016). Therefore, the hypothesis that the same circuit is likely to be 
involved in drug reinforcement is involved was tested. Thus, the songbird model is a 
promising model that allows the dertemination of the effects of the CNS active drugs 
during CNS development and how this exposure may generally impact all learning that is 
dependent upon intrinsic reinforcement. Moreover, the finding of the current study 
suggests that chronic developmental THC administration could be a gateway for 
increasing the sensitivity of drug of abuse by involving a persistent changing to DA 
system. On the other hand, to what extent that the eCB system is involved in the drug 
reward was first tested by Solianas and his group when they intravenously injected AEA 
and methanamide to rats. This group found an increase in the level of extracellular DA in 
the shell of the NAc that suggests the involvement of AEA in the reward processes 
(Solinas et al., 2006). However, in our study we revealed that chronic developmental JZL-
184 exposure did not alter the DA and DOPAC levels in VTA and Area X in response to 
cocaine later in life in adulthood. This could be explained by increased levels of 2-AG 
alone not mimicking the discriminative stimulus effects of THC (Hruba et al., 2015). 




(Gantz & Bean, 2017). Thus, further studies are needed to characterize the interaction 
and relationship between the eCB, particularly 2-AG, and DA systems when the 2-AG 
levels are manipulated during late-postnatal development.           
3.5.4 Developmental THC and JZL-184 Exposure Persistently Altered Neuronal Activity 
Measured Through c-Fos Expression  
Area X receives DA input from VTA/Sn in a manner similar to the dopaminergic 
reward circuit of mammalian ventral striatum (Person et al., 2008). In this study we found 
that chronic THC exposure increased the c-Fos level in Area X. Our results are consistent 
with most of the previous work that has reported an increase in neuronal activity in the 
limbic brain regions in response to drugs of abuse such as cocaine, amphetamine, 
(Graybiel et al., 1990) and morphine (Chang, Squinto, & Harlan, 1988).  A focus of drug 
abuse research has been to investigate neuronal activity in brain regions believed to be 
involved in addiction. These regions notably include striatum and the NAc (reviewed by 
Spear, 2016). Also, involvement of the neurotransmitters glutamate and DA are 
considered to be associated with drug abuse and addiction (reviewed by Spear, 2016). 
Glutamatergic excitatory neurons (Vanhoutte et al., 1999) and dopaminergic neurons 
(Badiani et al., 1998) induced c-Fos levels in the striatum and cocaine abuse is associated 
with elevated expression of c-Fos in CNS. For example, in rats, cocaine administration 
was found to induce c-Fos expression in striatum and this was inhibited by NMDA 
glutamate receptor antagonists (Torres & Rivier, 1993). Moreover, acute administration 
of THC increases c-Fos expression in limbic brain regions including striatum, and to a 
lesser degree the NAc (Erdtmann-Vourliotis, Mayer, Riechert, & Höllt, 1999). To the best 




developmental THC exposure and how that could be involved to increase the cocaine 
reinforcement in adulthood. We report here that THC exposure during development may 
increase neuronal activity that was indicated by the increased basal level of c-Fos 
expression in response to cocaine later in life. On the other hand, chronic development 
exposure to JZL-184 resulted in conditioned place aversion in response to cocaine 
challenge. This effect was accompanied with the increase of neuronal activity in TnA of 
amygdala as c-Fos level was higher in JZL-184 treated group compared to the control. 
The amygdala is known as a brain structure that is responsible for emotional responses, 
such as fear. In addition, the amygdala is connected to other brain regions by sending 
and receiving projections. These other regions include hypothalamus, VTA, NAc and 
olfactory cortex (Swanson, 2006). In one study, it was reported that both unconditioned 
and conditioned fear elevated the level of c-fos mRNA in the amygdala (Campeau et al., 
1991). Moreover, activation of c-Fos expression and overlap between some brain regions 
including amygdala, PFC, hippocampus, amygdala, hypothalamus were reported 
following shock-induced conditioned fear (Tulogdi et al., 2012). These previous studies 
support our finding that c-Fos activation in TnA of amygdala may be associated with the 
aversive effects following chronic and developmental JZL-184 exposure. Taken together, 
our c-Fos finding in this study demonstrated that the song brain regions may be involved 
in drug reward and aversion. These results suggest the positive and negative 
reinforcement effects that result from chronic and developmental THC and JZL-184 
respectively, which is indicated by the increased neuronal activity in brain regions that are 
important for reward or aversion, may increase spine densities that normally wane during 




densities in Area X while JZL-184 may elevate the spine densities in TnA of amygdala. 
For future work, it is important to test this hypothesis, knowing that early cannabinoid 
agonists exposure causes elevation in spine densities in song brain regions (Gilbert & 
Soderstrom, 2011).      
3.5.5 The Levels of Endocannabinoids (2-AG & AEA) in Brain Areas 
Following the 25 days of chronic injections with THC and JZL-184 and after waiting 
until maturation, animals were euthanized and the brain areas of interest such as Area X 
of striatum, VTA, and TnA of the amygdala were punched to determine the concentrations 
of 2-AG and AEA. We found that both chronic developmental THC and JZL-184 
administration decreased 2-AG level in Area X of striatum, TnA, and VTA while increased 
AEA in in Area X of striatum, and VTA levels. Interestingly, only chronic JZL-184 exposure 
was found to increase AEA content in TnA. Given that amygdala has a principal role in 
emotion, particularly fear, elevation the level of AEA in TnA of amygdala might be 
associated with JZL-184 aversion effect. In general, the evidence showing a relationship 
between stress and endocannabinoid levels are solid  (Morena, Patel, Bains, & Hill, 
2016). One of the main roles of the endocannabinoid system is to regulate the stress 
response. Stress exposure activates the HPA axis. This starts when the hypothalamus 
releases CRF in response to stress. CRF activates anterior pituitary gland to release 
ACTH. ACTH binds to its receptors in adrenal gland causing cortisol releasing (reviewed 
by Micale & Drago, 2018). The elevation of the level of cortisol in the body triggers 
endocannabinoid biosynthesis in brain in order to terminate and adapt the HPA axis. 
Moreover, FAAH levels increased in response to stress which ultimately led to decrease 




stress (M N Hill et al., 2013). In the current study, we found that AEA concentrations were 
increased in TnA of amygdala. The increasing AEA level may have a role in reducing the 
aversion effect that is seen after developmental JZL-184 treatment. This might occur after 
AEA binds to and activates pre-synaptic CB1Rs on glutaminergic neuron terminals in 
TnA. Inhibition of these excitatory synapses can result in reduction of neuronal activity, 
possibly contributing to reducing the aversion affects. In one study, glutaminergic 
neuronal activity has been found to be reduced in day one after stress in a model of post-
traumatic stress disorder (Fang et al., 2018). Future studies should investigate the 
excitatory/inhibition balance in amygdala by studying the activity and expression of 
glutaminergic and GABAergic neurons to understand how the endogenous cannabinoids 
(AEA and 2-AG) are involved in fear behavior.      
3.6 Conclusion 
In conclusion, here we found that early developmental exposure to THC and JZL-
184 resulted in conditioned-place preference and aversion respectively that persist 
through life. These effects are associated with increased neuronal activity in distinct limbic 
brain regions. This suggests that these regions are persistently altered by developmental, 
but not adult exposures to the exogenous cannabinoid, THC and also by enhancing 
signaling of the endocannabinoid 2-AG. The findings of the current study suggest that 
adolescents who abuse Cannabis may be more sensitive to the reinforcing effects of other 
drugs. This increased sensitivity may be due to persistently altered neuronal activity 
following early exposure. Moreover, another finding of the current work is that zebra 
finches are useful for studying drug reinforcement in addition to their well-established role 




ventral striatum is important for drug reward (Krebs et al., 2012), and vocal learning in 
zebra finches (Hoffmann et al., 2016). Moreover, Area X receives prominent 
dopaminergic input from ventral tegmentum (VTA) in a manner similar to the 
dopaminergic reward projection from mammalian VTA to ventral striatum (Person et al., 
2008). This suggests similar circuits that are responsible for vocal learning and production 
may also participate in drug reinforcement. More studies are needed to find the effects of 
early exposure of THC and JZL-184 on vocal learning and how this persistent change in 
brain may alter a learned behavior. Moreover, changes in the DA signaling in VTA or NAc 
may be accompanied with alteration of signaling by other neurotransmitters, thus, 
research into the role of other neurotransmitters such as glutamate may provide more 





Figure 3.1. JZL-184 (4 mg/kg) increases 2-AG levels 
JZL-184 (4 mg/kg) increases 2-AG levels to almost double that of vehicle-treated 
animals after 20 minutes. Treatments were delivered via IM injection once to adult zebra 










Figure 3.2. Developmental JZL-184 (4 mg/kg) exposure caused aversion while 
THC (3 mg/kg) increases the preference in response to cocaine challenge test 
THC (3 mg/kg) increases sensitivity of the adult songbird to cocaine when 
delivered during a sensitive period of vocal learning, while JZL184 (4 mg/kg) causes 
aversion. Those effects were reversed by pretreatment with the CB1-selective antagonist 
SR and demonstrates CB1 receptor mediation of the preference and aversion behaviors.  
Daily treatments were administered for 25 days from 50-75 days of age in developing 
animals.  Animals were allowed to mature an additional 25 days following treatments to 
adulthood. Differences were determined using one-way ANOVA followed by Newman-










Figure 3.3. Adult JZL-184 exposure has no clear effect on drug reinforcement 
Daily treatments were administered for 25 days to adults (>= 100 days). Animals 
in the adult treatment group were not manipulated for 25 days post-treatment to simulate 
the maturation period of the developmental group (see Figure 3.2). Differences were 















Figure 3.4. Striatal and midbrain DA & DOPAC levels increased following 
developmental THC, but not JZL-184 treatments  
Developing animals (50-75 days old) were treated with vehicle, the partial agonist 
THC (3 mg/kg) or the MAG lipase inhibitor JZL-184 (4 mg/kg). Treatments were followed 
by 25 days of no treatment in order to allow developing animals to mature. Animals were 
placed back into their cocaine-paired chambers on the day following final preference tests 
and euthanized 15 min later. Significant increases in DA (A) and DOPAC (B) levels were 
observed following developmental THC treatments. Differences were determined using 
one-way ANOVA analysis followed by Newman-Keuls post-tests. *p < 0.05 vs. Vehicle. 










Figure 3.5. DA & DOPAC levels increased following developmental THC and JZL-
184 treatments 
Songbirds during adolescent development (50-75 days old) were treated with 
vehicle, partial agonist THC (3 mg/kg) or MAG Lipase inhibitor JZL184 (4 mg/kg). 
Treatments were followed by 25 days of no treatment in order to allow developing animals 
to mature. Animals were placed back into their cocaine-conditioned chambers on the day 
following final preference tests and euthanized 15 mins later. A, a significant increase in 
DA levels was observed following developmental THC treatments. B, there was not 
different in DOAPC levels among groups. Differences were determined using one-way 
ANOVA analysis (p = 0.06) followed by Newman-Keuls post-tests. *p < 0.05 vs. Vehicle. 









Figure 3.6. Developmental THC increases striatal c-Fos expression following 
placement in cocaine-paired chambers 
Developmental THC exposure increases basal densities of c-Fos reactive nuclei 
within both Area X and medial striatum. Initial daily treatments over 25 days are indicated 
by first designations (VEH-, THC-). Later, animals were placed back in CPP apparatus to 
stimulate c-Fos expression in adulthood are indicated second (-VEH, -COC). Treatments 
were delivered during sensorimotor song learning (from 50 to 75 days) and measured in 
adulthood (>110 days). In F, levels of c-Fos expression are elevated following repeated 
THC exposure during development in Area X (compare VEH-VEH vs. THC-COC and 
THC-VEH vs. THC-COC). Asterisks indicate differences from VEH-VEH treatment groups 
(p < 0.05, one-way ANOVA followed by Tukey post-tests). Pound indicates a difference 
from THC-VEH group (p < 0.05, one-way ANOVA followed by Newman-Keuls post-tests). 








Figure 3.7. Developmental JZL-184 decreases striatal c-Fos expression following 
placement in cocaine-paired chambers 
Developmental JZL-184 exposure increases basal densities of c-Fos reactive 
nuclei within TnA. Initial daily treatments over 25 days are indicated by first designations 
(VEH-, JZL-). Later, animals were placed back in CPP apparatus to stimulate c-Fos 
expression in adulthood are indicated second (-VEH, -COC). Treatments were delivered 
during sensorimotor song learning (from 50 to 75 days) and measured in adulthood (>110 
days). In C, levels of c-Fos expression are elevated following repeated JZL184 exposure 
during development in TnA (compare VEH-VEH vs. JZL-COC and JZL-VEH vs. JZL-
COC). Asterisks indicate differences from VEH-VEH treatment groups (p < 0.05, one-way 
ANOVA followed by Tukey post-tests). Pound indicates a difference from JZL-VEH group 
(p < 0.05, one-way ANOVA followed by Newman-Keuls post-tests). JZL = JZL-184 and 








Figure 3.8. Developmental THC & JZL-184 decreases 2-AG level in TnA, and VTA 
Developmental animals (50-75 days old) treated with vehicle, partial agonist THC 
(3 mg/kg) or MAG Lipase inhibitor JZL-184 (4 mg/kg). Treatments followed by 25 days of 
no treatment in order to allow developing animals to mature. Animals were placed back 
into their cocaine-conditioned chambers on the day following final preference tests and 
euthanized 15 mins later. Significant decreases in 2-AG levels was observed following 
developmental THC and JZL-184 treatments in TnA and VTA. Differences were 
determined using one-way ANOVA analysis followed by Newman-Keuls post-tests. 











Figure 3.9. Developmental THC & JZL-184 persistently increases AEA levels in the 
Area X of striatum, TnA of amygdala, and VTA 
Developmental animals (50-75 days old) treated with vehicle, partial agonist THC 
(3 mg/kg) or MAG Lipase inhibitor JZL-184 (4 mg/kg). Treatments followed by 25 days of 
no treatment in order to allow developing animals to mature. Animals were placed back 
into their cocaine-conditioned chambers on the day following final preference tests and 
euthanized 15 mins later. Significant increases in AEA level was observed following 
developmental THC and JZL-184 treatments in Area X, TnA and VTA. Differences were 
determined using one-way ANOVA analysis followed by Newman-Keuls post-tests. 








Figure 3.10. Illustration of zebra finch song brain regions.  
Dark purple arrows indicate connections of the anterior forebrain pathway (AFP), 
a cortico-basal ganglia-thalamic loop critical for sensorimotor vocal learning. Light purple 
arrow illustrates AFP output from lMAN to the vocal motor output region, RA. Dark grey 
indicates vocal motor pathways, light grey illustrates the output from pre-motor HVC to 
the basal ganglia region, Area X. Light gold arrows indicate relevant auditory input to the 
motor system and from the ventral portion of the intermediate arcopallium (AIV) to 
dopaminergic neurons within substantia nigra (SN)/VTA. Dark gold indicates SN/VTA 
dopaminergic projections to spiny interneurons within Area X. Abbreviations: DLM 
(nucleus dorsolateralis anterior, pars medialis), HVC (proper name), lMAN (lateral 
magnocellular nucleus of the anterior nidopallium), NCM (caudal medial nidopallium), RA 
















CHAPTER 4: DEVELOPMENTAL THC AND JZL-184 EXPOSURE PERSISTENTLY 
ALTER SONG PHONOLOGY THROUGH ADULTHOOD 
4.1 Introduction 
In our previous work, we showed that both chronic THC and JZL-184 exposure 
during adolescence increased zebra finch sensitivity to cocaine into adulthood (chapters 
2 and 3). We found that 3 mg/kg THC acts as a positive reinforcer while 4 mg/kg JZL-184 
acts as a negative reinforcer.  Interestingly, increasing the sensitivity to cocaine later in 
life following both THC and JZL-184 was accompanied with many physiological changes 
including the DA & DOPAC level, c-Fos expression, and the levels of the 
endocannabinoids (AEA & 2-AG) in brain areas including Area X of striatum and TnA of 
amygdala.  
Previously in our lab, it has been found that chronic WIN55212-2, a full agonist 
cannabinoid, treatments during adolescence, not adulthood, causes: 1) altered song 
learning (Soderstrom & Johnson, 2003) and; 2) persistently altered axonal and dendritic 
spine densities in zebra finch brain regions that are important for song (Gilbert & 
Soderstrom, 2011, 2014; Soderstrom, Poklis, & Lichtman, 2011). Also, it has been found 
that acute cannabinoid treatments inhibit expression of the immediate-early genes zenk 
and Arc/Arg3.1 expression in NCM, one of the auditory perception regions, which in turn 
affects song recognition (Gilbert & Soderstrom, 2013).  
However, as THC is the main psychoactive constitute of Cannabis, to best of our 
knowledge, there is limited data about the effects of THC on vocal learning behavior. 




critical period of song learning or not. As mentioned above in chapter 1, the zebra finch 
song brain regions contain high levels of CB1 receptors and 2-AG, and their levels change 
over the course of development (Soderstrom & Wilson, 2013). Preliminary evidence that 
CB1 receptor antagonism alters song in a manner similar to agonists suggests that this 
is the case, but it has not yet been experimentally-confirmed.   
Therefore, we tested the hypothesis that both chronic developmental THC and 
JZL-184 exposure increase the variability of songs in a manner similar to increasing the 
sensitivity to cocaine in the zebra finch (see chapters 2 and 3). 
4.2 Method & Materials 
4.2.1 Materials 
The phytocannabinoid partial agonist THC was obtained from the NIDA drug 
supply program. Equithesin was prepared from reagents (40% propylene glycol, 10% 
ETOH, 5% chloral hydrate, 1% pentobarbital). Immunochemicals were purchased from 
Vector Laboratories (Burligame, CA). MAG Lipase inhibitor (JZL-184) and rimonabant, 
also known as SR141716 were purchased from Santa Cruz Biotechnology (Santa Cruz, 
California). Alkamuls EL-620 was purchased from (Rhodia, Cranberry, NJ). DMSO and 
sucrose were purchased from Fisher Scientific (Pittsburgh,PA) . Prism data analysis 
software was purchased from GraphPad (San Diego, CA).  
4.2.2 Drug Treatment 
Drugs were delivered in 50 µl via IM injection into pectoralis muscle using 30 ga 




period of 25 days. For developmental exposures, treatments were given from 50 – 75 
days of age during a period of sensorimotor vocal learning. Following developmental 
treatments, animals were allowed to mature to adulthood at 100 days of age. For adult 
exposures, mature animals (>=100 days of age) were given 25 daily injections and were 
unmanipulated for an additional 25 days to simulate the maturation period in the 
developmental group. Following the maturation or simulated maturation period, animals 
underwent vocalizations recorded testing as described below. 
4.2.3 Animals and Audio Recording Environment  
Following treatments, at age 110 days, the male adult songs were recorded. The 
recording took place in a recording room (14/10-hour light/dark cycle) that is equipped 
with chambers with lights and microphones. The birds had free access to water and food. 
Prior to recording, habituation took place for 3 days. The birds were visually isolated 
during the experiments and were not female-directed. Songs were recorded by using 
Sound Analysis Recorder software stored in Waveform Audio File (WAV) format. All 
animal procedures were approved by the East Carolina University Animal Care and Use 
Committee. 
4.2.4 KL Distance Measures of Phonology 
Songs were segmented into syllables using Sound Analysis Pro 2011 (SAP 2011) 
software (Tchernichovski, Nottebohm, Ho, Pesaran, & Mitra, 2000). Segmentation using 
SAP was done by thresholding based upon entropy, syllable and syllable gap durations. 
SAP characterizes syllables with measures of 14 acoustic parameters (e.g. syllable 




goodness of pitch, mean frequency, pitch variance, FM variance, entropy variance, 
goodness of pitch variance, mean frequency variance, AM variance). Kullback-Leibler 
(KL) distances, a statistical method to compare two 2D probability distributions that 
developed by (Daou, Johnson, Wu, & Bertram, 2012; Elliott, Wu, Bertram, & Johnson, 
2014), was used to assess the phonology using the acoustic features measures. Greater 
KL distance means greater divergence of patterns. We used acoustic measures from 
vehicle-treated animal recordings as “template” distributions, and recordings from each 
group of treatments as individual “targets”. KL distances between template and target 
distributions were calculated using software we developed (KLFromRecordingDays) 
available for download as described in Soderstrom and Alalawi, 2017). 
4.2.5 Statistical Analyses 
To assess differences in phonology and vocal production across treatment groups, 
we used one-way ANOVA followed by Newman-Keuls post-hoc tests. Statistical analyses 
were done using GraphPad Prism software. Probabilities less than 0.05 were considered 
significant. Means +/- standard error or 95 % confidence interval are reported as 
indicated. 
4.3 Results 
4.3.1 Developmental THC and JZL-184 Increased KL Distance Measures 
KL distances, a measure of phonological variance, differed across treatments after 
developmental exposures (Figure 4.1). Developmental treatments (n = 8) altered the KL 




developmental treatments, THC and JZL-184-treated animals showed significantly higher 
KL distance measures (including all the acoustic features) than vehicle treated animals 
(Figure 4.1A). The 3 mg/kg THC dosage significantly increased KL distance by 2.1 ([2.1-
4.2], p=0.023). The 4 mg/kg JZL-184 dosage significantly increased KL distance by 2.5 
([2.1-4.6], p=0.0048). Treatment with the SR antagonist (6 mg/kg) prior to administration 
of both 3 mg/kg THC and 4 mg/kg lowered KL distances by 0.5 ([3.6-4.2], p=0.4 and; 2 
[4.6-2.6], p=0.007, respectively). Adult treatments showed no clear effects on KL distance 
measures (F [5, 42], p=0.156, 1-way ANOVA) in figure 4.1B. Specifically, developmental 
THC and JZL-184-treated animals had higher KL distance at amplitude (by 5.2 [3.9-9.1], 
p=0.003, 3.4 [3.9-7.3], p=0.03, respectively) and entropy (by 3 [4.0-7.0], p=0.03, 3 [4.0-
7.0], p=0.017, respectively) of songs compared to vehicle-treated animals (Figure 4.2). 
4.3.2 THC and JZL-184 Have No Effects on Motif Syllable Numbers 
Number of motif syllables, a stereotyped sequence of syllables (figure 4.5), was 
counted based on the KL distance outputs (Figure 4.4). There were no significant 
differences in the number of motif syllables across treatment groups following both 
developmental and adult exposure. 1-way ANOVA was done separately for both the 
developmental and adult groups, and their results were p=0.96 and p= 0.063, 
respectively.  
4.4 Discussion & Conclusion  
This study demonstrated that the chronic developmental THC and JZL-184 
exposure persistently increases song variability in adulthood. As we expected, the 




demonstrate that the effects of both THC and JZL-184 on song phonology were specific 
to the learning and development of songs during a critical period of learning 
(adolescence). Alterations of the song phonology during adolescence could be the result 
of THC and JZL-184 effects on neuronal development. In zebra finches, the circuit of 
basal ganglia-thalamocortical, anterior forebrain pathway (Area X >> Dlm >> lMAN >> 
Area X) is required for songbird vocal learning until the maturation of stereotyped song 
that leads to “hand off” of control to a motor cortical circuit (HVC >> RA) (Bottjer, Miesner, 
and Arnold 1984; Herrmann and Arnold 1991). This was demonstrated by quantitative 
electron microscopic studies (EM) that measured the motor cortical synaptic densities 
(within RA) derived from afferents from the learning circuit output, lMAN and the motor 
circuit output, HVC (Herrmann & Arnold, 1991). The quantitative EM had been done using 
three different groups of ages, 25-day, 53 day, and adulthood. They found that the density 
and total number of RA synapses derived from the learning circuit output lMAN decreased 
significantly between days 25 and 53 and did not change thereafter. In contrast, the 
density and total number of synapses in RA derived from HVC increased significantly 
between days 25 and 53 but did not change significantly thereafter. This result suggested 
the importance of lMAN in learning processes at early age, as well as the importance of 
HVC for song production in adulthood (Herrmann & Arnold, 1991). The anterior forebrain 
pathway and its lMAN projection neurons to RA seems to be responsible for vocal 
variations after HVC microlesion (Kao, Doupe, & Brainard, 2005; Thompson & Johnson, 
2007; Vu, Mazurek, & Kuo, 1994). This was confirmed after lMAN ablation prior the HVC 
microlesion prevented vocal disruption (Thompson & Johnson, 2007). Moreover, some 




songs that indicates a potential mechanism of how cannabinoid agents affect vocalization 
by interfering and preventing the normal “hand-off” of RA control by lMAN to HVC. Thus, 
developmental THC- and JZL-184-altered song phonology may involve inappropriate 
involvement of learning circuit control over vocal motor programs. The role of lMAN output 




Figure 4.1. KL distance measures of phonology for different treatment following 
developmental and adult exposure 
Developmental (50 – 75 days of age, panel A) and adult (>=100 days of age, panel 
B) animals were given once daily IM injections for 25 days period as described above in 
the method section. Following the maturation or simulated maturation period, animals 
underwent vocalization recording. We used acoustic measures from vehicle-treated 
animals’ recordings as template distributions, and recordings from each group of 
treatments as individual targets. KL distances between template and target distributions 
were calculated using KL distance software. Greater KL distance means compared to 
vehicle, greater divergence of patterns. In developmental animals, KL distances are 
clearly increased in THC and JZL-184-treated animals indicating significant song 
variability compared to the vehicle-treated group. Pre-treatment animals with SR reduced 
the KL distances measures. In adult group, both THC and JZL-184 has no clear effects 
on KL distance measures compare to vehicle-treated animals. Differences were 
determined using one-way ANOVA (p = 0.005) followed by Newman-Keuls post-tests. *p 








Figure 4.2. Developmental THC and JZL-184 exposure increase amplitude and 
entropy vocal variance through adulthood 
The THC and JZL-184-treated animals have higher mean KL distance at amplitude 
(by 5.2 [3.9-9.1], p=0.003, 3.4 [3.9-7.3], p=0.03, respectively) and entropy (by 3 [4.0-7.0], 
p=0.03, 3 [4.0-7.0], p=0.017, respectively) of songs compared to vehicle-treated animals. 
Differences were determined using one-way ANOVA followed by Newman-Keuls post-









Figure 4.3. Adult THC and JZL-184 exposure have no clear effects on the KL 
distance at any acoustic parameters 
KL distance at each acoustic parameter did not show any song variability when 






   
 




Figure 4.4. THC and JZL-184 had no effect on song production measured as motif 
syllables uttered per hour 
No treatment group sang significantly more- or less complicated song patterns when 
compared to other groups following both chronic developmental and adult exposure 









Figure 4.5. A sonogram example demonstrating the difference between the motif 












CHAPTER 5: CONCLUSION AND FUTURE DIRECTIONS 
5.1 General Discussion  
The present study was conducted to evaluate the effects of chronic developmental 
THC exposure on a learned behavior such as drug reinforcement and vocal learning that 
persist through adulthood, to further understand the role of endocannabinoid signaling 
during a critical period of development (adolescence), and the degree to which similar 
neuronal circuits control both of these behaviors. The zebra finch was used as the model 
for drug reward and vocal learning 
 In Aim 1, we developed a new animal model, through the use of zebra finches to 
study drug reinforcement of behavior in adulthood after drug exposure during a critical 
period of development. Zebra finch songbirds are natural vocal learners that learn how to 
communicate and sing during a sensitive and critical period of life (Eales, 1985). Because 
of this, they represent an animal model suitable for studying neurobiology underlying 
maturational stage-dependent learning ability (Mello, 2014). Exposure to cannabinoid 
drugs during this sensitive period of development results in alterations of vocal learning 
(Soderstrom & Johnson, 2003).   
As this model is useful to study drug effects during development, the missing gap 
is to use this model study the drug reinforcement of behaviors. In this study, a modified 
conditioned place preference (CPP) paradigm was used to evaluate the rewarding and 
aversive effects of a drug. CPP paradigm involves the Pavlovian association of a 
particular environment with a drug treatment or some other stimulus.  Adult zebra finch 




mg/kg in the least preferred chamber in order to find the appropriate cocaine dosage that 
can be used in the following experiments. The dose response curve showed the EC50 
was 2.5 mg/kg. At this dosage, we found that half of the animals preferred the cocaine-
associated compartment while the other half preferred the vehicle-associated 
compartment. Consistent with other vertebrate studies, cocaine dose-dependently 
produced place preference in our model with a potency similar to rodents (Mueller & 
Stewart, 2000). In addition, cocaine was found to initially induce place preference that 
followed by aversion in rats (Su et al., 2013). This finding was consistent with our results 
for the chamber placement delay experiment. Animals who were placed back into the 
CPP apparatus after 1, 5, or 10 minutes after injection of 2.5 mg/kg cocaine developed 
preference for the cocaine-paired side, while animals who were placed back after 15 or 
30 minutes developed aversion. As our dose-response study employed a five-minute 
chamber placement delay following injections of cocaine, for consistency we chose to 
continue to use this time in the following experiments.           
The effects of different drugs of abuse in rodents after chronic adolescence 
exposure has been evaluated (Linda Patia Spear, 2016). In rats, it was found that 
periadolescent exposure to nicotine increased self-administration (W Adriani et al., 2002). 
Moreover, adolescent exposure to nicotine was reported to increase sensitivity to cocaine 
or diazepam following maturation (McMillen et al. 2005; James-Walke et al., 2007). In our 
study, we found that chronic developmental THC exposure, but not adult THC treatment, 
increased sensitivity to cocaine through the adulthood. However, the developmental 




result was not significant compared to the vehicle group and this could be due to the 
positive reinforcing effects of using an ethanol-containing vehicle.  
Previous studies have reported that the administration of cocaine increased neuronal 
activity in the striatum in rats (Graybiel et al., 1990). In our study, distinct changes in 
neuronal activity as indicated by changes in c-Fos expression suggest that brain regions 
known to be important for vocal learning (Area X and lMAN) and motor production (HVC 
and RA) are also involved in drug-induced reinforcement of behavior.   
Taken together, these finding suggests that zebra finch model is a potential model to 
study the effects of developmental drug exposure in drug reinforcement.  
The focus of Aim 2 was to compare the developmental influence of elevated levels 
of the endogenous cannabinoid 2-AG to effects of the exposure to exogenous THC on 
the drug reinforcement. These results improve our understanding of the involvement and 
the role of the endocannabinoid signaling in learning related to both drug abuse and vocal 
communication. 2-AG is one of the principal endogenous cannabinoids along with AEA 
in the brain (Mechoulam et al. 1995). JZL-184 is a MAGL inhibitor that increases 2-AG 
levels in brain (Long et al., 2009). Availability of a selective pharmacological tool to block 
the degradation of 2-AG helps to understand the role of eCB system in some pathological 
conditions such as pain, cancer and addiction. Moreover, the eCB system was found to 
be involved in addiction of many drugs of abuse such as alcohol, opiates, and nicotine 
(González et al., 2002; Simonnet et al., 2013; Viganò et al., 2003). Limited data are 
available, however, from the evaluaition of the chronic elevation of 2-AG levels in a 




Our current study investigated the persistent behavioral effect of chronic and 
developmental JZL-184 (indirect cannabinoid agonist) exposure through adulthood. A 
conditioned place preference (CPP) was used to evaluate cocaine reinforcement after 
developmental and adult treatments. While exogenous THC exposure caused a positive 
cocaine reinforcement, developmental JZL-184 exposure caused a negative cocaine 
reinforcement (Figure 3.2). Even though the adult JZL-184 treatments decreased 
preference scores compared to the vehicle group, it did not result in an aversive effect 
(Figure 3.3). Similar to what was found in a study that used a mouse model, a systemic 
JZL-184 treatment was found to promote conditioning-fear in mice (Llorente-Berzal et al., 
2015). Moreover, JZL-184 administration resulted in impairment in fear extinction 
(Llorente-Berzal et al., 2015). These findings demonstrate that THC increases sensitivity 
to the positive reinforcing effects of cocaine, while the JZL-184 sensitizes negative 
cocaine reinforcement. This suggests that each drug modulates activity within distinct 
brain regions. 
The limbic system mediates the brain reward of most CNS active drugs 
(Duvauchelle et al., 2000). In our zebra finch model, Area X receives DA input from 
VTA/Sn in a manner similar to the dopaminergic reward circuit of mammalian ventral 
striatum (Person et al., 2008). In our current study, we found that the concentrations of 
DA and DOAPC increased in Area X and VTA following the developmental chronic THC 
treatments (Figure 3.4 & 3.5). DA and DOPAC level did not increase after the JZL-184 
exposure. These results concur with other reports in which acute and repeated THC 
administration were found to be associated with the increased levels of DA in NAc, 




findings suggest that elevating the DA and DOPAC contents in Area X and VTA might be 
involved in cocaine reinforcement after developmental THC exposure.  
c-Fos is a proto-oncogene that expressed in neurons and used as an indirect 
marker of neuronal activity (VanElzakker, Fevurly, Breindel, & Spencer, 2008). In 
addition, high c-Fos expression indicates a recent neuronal activity (Dragunow & Faull, 
1989). In our current study, the neuronal activity in brain regions that are important for 
song learning and production were investigated following chronic THC and JZL-184 
treatment and cocaine challenge. Interestingly, THC exposure was found to increase the 
striatal c-Fos level (Figure 3.6) while the JZL-184 exposure decreased striatal c-Fos 
expression and increased it in TnA of amygdala (a brain region that is responsible for 
emotions including fear, Figure 3.7).  These findings are consistent with what was 
reported by Graybiel and his collogues when they found that neuronal activity (indicated 
by increasing c-Fos levels) increases within striatum after the administration of cocaine 
(Graybiel et al., 1990). Moreover, both unconditioned and conditioned fear were found to 
elevate levels of c-fos mRNA in amygdala (Campeau et al., 1991).  These findings 
suggest that these different brain regions may be responsible for the behavioral 
differences following chronic and developmental THC and JZL-184 treatments.  
Many studies have reported that the eCB system is involved in abuse of alcohol, 
nicotine and opiates. Those drugs were found to alter the levels of the endogenous 
cannabinoids including AEA and 2-AG (González et al., 2002; Simonnet et al., 2013; 
Viganò et al., 2003). In our current study, there was a pattern of reduction in the 2-AG 
levels in the Area X, TnA of amygdala, and VTA after both developmental THC and JZL-




amygdala, and VTA was found (Figure 3.9). Interestingly, high level of AEA in TnA of 
amygdala after JZL-184 exposure compared to the vehicle and THC groups was notable. 
Other reports found that neither FAAH inhibition (the enzyme responsible for AEA 
degradation) nor MAGL inhibition (2-AG degradative enzyme) alone increased reward 
behaviors or drug reinforcement (Panlilio et al., 2013). However, concurrent 
administration of FAAH with MAGL inhibitors lead to an increase in self-administration of 
cocaine, a result that suggests a need to robustly elevate of both AEA and 2-AG in order 
to give produce THC-like discrimination effects (Wiley et al., 2014; Wise et al., 2012). 
Interestingly, our results suggest that JZL-184 may exert its effects by acting in brain 
regions where normal tonic eCB signaling takes place, (regions such as VTA, striatum, 
TnA of amygdala, hippocampus, hypothalamus) and thus indicate their importance roles 
in regulating behaviors such as rewarding, stress, memory, and appetite, whereas the 
THC will affect the entire brain. Moreover, in the zebra finch model, the normal tone of 
eCB signaling in song brain regions (e.g. Area X of striatum) is important particularly 
during the sensorimotor period of learning where higher level of eCB activity is occurring.  
Thus, any perturbation or dysregulation to eCB neurotransmission may affect learned 
behaviors.  
The focus of Aim 3 was to evaluate the effects of THC as well as the role of the 
endogenous cannabinoids on song learning during critical period of development. In 
addition to that, THC and JZL-184 caused positive and negative cocaine reinforcement 
effects, both of these treatments increased the mean KL distance measures which 
indicates high song variability within drug treated groups compared to the vehicle control 




be due to altered activity within similar brain regions.  Our c-Fos results indicate changes 
in neuronal activity within specific brain regions that includes those regions important for 
song learning and production.  For example, we found that chronic developmental THC 
treatments increased the c-Fos levels in Area X, while JZL-184 decreased compared to 
the vehicle groups. Area X is known to be important for song learning that is normally 
active at an early age when song learning process occur, However, during the 
development and maturation, the pathway that is responsible for song production 
becomes more active. Therefore, THC and JZL-184 exposure might lead to a selective 
upregulation of neuronal activity in one of these regions, this will provide important 
indication of learning- and motor-circuit regions that are persistently altered, and provide 
novel insight to circuits influenced by Cannabis abuse. Moreover, given distinct 
neurochemistry in the regions studied (e.g. basal ganglia is enriched with GABAergic and 
dopaminergic signaling) results will inform potential therapeutic approaches to address 
problems associated with cannabinoid-altered development. GABAergic and 
dopaminergic system drugs could be tested to find whether it improves song or not. 
5.2 Future Directions 
Research targeting enzymes is one of main focus of drug research in order to 
discover new treatments for diseases. JZL-184 was developed in 2009 as the first 
selective blocker of 2-AG degradation. Recently, much research is focusing on using JLZ-
184 as an analgesic in pain models. One of the main findings of our current study is that 
the JZL-184 treatment did not mimic THC effects. We found that the chronic 
developmental JZL-184 exposure reduced the preference score in response to cocaine 




administration of cocaine could be a potential approach to treat cocaine addiction. The 
administration of amperozide, a 5HT2A receptor and FAAH inhibitor prior to cocaine 
prevented a cocaine-induced place preference (Jones and McMillen, 1995).  A proposed 
experiment may involve giving a systemic JZL-184 treatment before cocaine injections 
and then measure the neuronal activity in brain regions in which cocaine induced c-Fos 
expression (e.g. brain regions such as striatum, VTA and amygdala, see chapter 2 and 3 
above). The results of this experiment will help us to understand if JZL-184 will acutely 
reduce the preference score prior to the administration of cocaine and to find the brain 
regions that are involved in drug reinforcement in the songbird model. 
 The study of the neurophysiological changes that occur after chronic 
developmental THC and JZL-184 exposure that are associated with the persistent 
increase in cocaine sensitivity and alteration of vocal behaviors are important to 
understand what areas in the brain are responsible for both the negative and positive 
effects following the chronic developmental cannabinoid exposure. Generally, late-
postnatal CNS development is associated with a reduction in dendritic spine densities 
across the CNS (Changeux, 1997; Changeux & Dehaene, 1989). This is true of our 
songbird model and includes Area X and lMAN, which indicates both activity- and 
experience-driven synaptic changes (Gilbert & Soderstrom, 2011, 2014; Soderstrom et 
al., 2011). Previously, our lab reported that chronic cannabinoid treatments during 
adolescence, not adulthood, causes persistently altered axonal and dendritic spine 
densities in zebra finch brain regions that are important for song (Gilbert & Soderstrom, 
2011, 2014; Soderstrom et al., 2011). Therefore, chronic THC or JZL-184 may affect the 




reinforcement and altered vocal behaviors. Golgi-Cox staining can be used to study the 
morphological changes of neurons in several brain regions. This will help us to study and 
to more understand the behavioral-morphological relationships. 
Additionally, the hypothesis that whether the cannabinoid-altered development is 
attributable to inappropriate involvement of learning circuit control over vocal motor 
activity is worthy to be tested as some of reports showed that lMAN projections to RA are 
responsible for song variations - and this was prevented after lMAN ablation (Thompson 
& Johnson, 2007). Songs will be recorded following reversible lMAN inactivation by a 
sodium channel blocker, tetrodotoxin. We will test the hypothesis that song patterns 
altered by daily exposure to THC (3 mg/kg) or JZL-184 (4 mg/kg) will improve under lMAN 
inactivation conditions and degrade as the effect of the sodium channel block wanes. 
Dye-conjugated dextrans will be added to the microinfusion solutions for histological 
confirmation of infusion site. If this expected result is not confirmed, we will repeat 
experiments except that lMAN will be lesioned as in preliminary experiment (Elliott et al., 
2014). Quantitative EM experiments will be done to measure the number of synapses in 
motor cortical region RA derived from pre-motor HVC, and the learning circuit output 
lMAN. The ratio of lMAN:HVC derived synapses in RA decreases during the course of 
normal development. We will test the hypothesis that exposure to cannabinoid treatments 
during development, but not in adults, alters learning by preventing this normal 
developmental change, resulting in a high ratio of lMAN: HVC synapses and inappropriate 
lMAN control over RA activity. Therefore, the fraction of total synapses derived in RA from 
lMAN or HVC after lesion or treatments will be determined by using TEM methods as 




synapses in RA as a function of developmental cannabinoid treatments and following 
ablation of each region. If our hypothesis is confirmed, this will indicate that exposure to 
cannabinoid treatment during development that altered learning inhibits the normal “hand 
off” of the learning circuit to the motor control of learned behavior. This is consistent with 
our hypothesis that cannabinoids act to maintain stasis, preserving immature phenotypes 
following developmental exposure (Soderstrom & Gilbert, 2013).  This finding will suggest 
that the now well-established persistent behavioral effects following early onset Cannabis 
abuse likely involve a similar interference with maturation of neural circuits for learning 
that involve a similar transition from ventral to dorsal striatal circuits (Volkow et al., 2006).  
Even though we measured c-Fos levels as an indirect marker for recent neuronal 
activity, doing electrophysiology studies can help to record the electrical activity in specific 
brain regions such as Area X and TnA of amygdala following chronic THC and JZL-184 
treatments.  The electrophysiology experiments will help us to find out exactly which brain 
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